Medicines Amendment Regulations 2018 Regulations · 190 Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection;

Medicines Amendment Regulations 2018

Patsy Reddy, Governor-General

Order in Council

At Wellington this 24th day of September 2018

Present:Her Excellency the Governor-General in Council

These regulations are made under section 105(1)(j) of the Medicines Act 1981—(a) on the advice and with the consent of the Executive Council; and(b) on the advice of the Minister of Health tendered after consultation with the

organisations or bodies appearing to the Minister to be representative of per-sons likely to be substantially affected.

ContentsPage

1 Title 12 Commencement 23 Principal regulations 24 Schedule 1 replaced 25 Regulations revoked 2

ScheduleSchedule 1 replaced

2

Regulations

1 TitleThese regulations are the Medicines Amendment Regulations 2018.

2018/179

1

http://prd-lgnz-nlb.prd.pco.net.nz/pdflink.aspx?id=DLM56564


2 CommencementThese regulations come into force on the 28th day after the date of their notifi-cation in the Gazette.

3 Principal regulationsThese regulations amend the Medicines Regulations 1984 (the principal regu-lations).

4 Schedule 1 replacedReplace Schedule 1 with the Schedule 1 set out in the Schedule of these regula-tions.

5 Regulations revokedThe Medicines Amendment Regulations (No 2) 2015 (LI 2015/180) arerevoked.

ScheduleSchedule 1 replaced

r 4

Schedule 1Prescription, restricted, and pharmacy-only medicines

r 3

Every reference to a medicine in this schedule applies whether the medicine is syn-thetic in origin or is from biological or mineral sources.Unless specific reference is made otherwise, every reference applies also to medicinesthat are—• preparations and admixtures containing any proportion of any substance listed

in this schedule:• salts and esters of any substance listed in this schedule:• preparations or extracts of biological materials listed in this schedule:• salts or oxides of elements listed in this schedule.Unless specific reference is made otherwise, every reference to a medicine in thisschedule applies,—• if the medicine is an injection or eye preparation, to any concentration of that

medicine; and• if the medicine is not an injection or eye preparation, only if the concentration

of the medicine is greater than 10 milligrams per litre or per kilogram.

r 2 Medicines Amendment Regulations 2018 2018/179

2




Where any reference is modified by a statement of the strength of the medicine, thestrength is calculated using the free acid, base, alcohol, or element unless specificallystated otherwise.

Part 1Prescription medicines

Amending or replacing this Part may affect designated prescriber regulations undersection 105(1)(q) of the Act.1 19-norandrostenedione2 2,4-dinitrochlorobenzene3 4-aminopyridine4 4-chloromethandienone5 4-chlorotestosterone6 5-aminolevulinic acid7 Abacavir8 Abatacept9 Abciximab10 Abiraterone11 Abrus precatorius; at all strengths12 Acamprosate13 Acarbose14 Acebutolol15 Acepromazine16 Acetanilides17 Acetarsol18 Acetazolamide19 Acetohexamide20 Acetylcarbromal21 Acetylcholine; except in medicines containing 1 milligram or less per litre or

per kilogram22 Acetylcysteine; for injection or inhalation23 Acetyldigitoxin24 Acetylmethyldimethyloximidophenylhydrazine25 Acetylstrophanthidin26 Aciclovir; except when specified elsewhere in this schedule27 Acipimox

2018/179 Medicines Amendment Regulations 2018 Schedule

3

28 Acitretin29 Aclidinium bromide30 Acokanthera ouabaio31 Acokanthera schimperi32 Aconitum spp; except when specified elsewhere in this schedule33 Acrivastine34 Adalimumab35 Adapalene; except in medicines containing 1 milligram or less per millilitre or

gram and when supplied by a pharmacist in a pack containing not more than 30grams for the treatment of comedo, popular, and pustular acne (acne vulgaris)of the face, chest, or back

36 Adefovir37 Adenosine; for injection38 Adinazolam39 Adiphenine40 Adonis vernalis41 Adrafinil42 Adrenal extract; except for dermal use in medicines containing 0.02% or less

of ketosteroids43 Adrenaline; in medicines containing more than 1%44 Adrenocortical hormones; except adrenal extract for dermal use containing

0.02% or less of ketosteroids45 Afamelanotide46 Afatinib47 Aflibercept48 Agalsidase49 Agomelatine50 Alatrofloxacin51 Albendazole52 Albumin; except human albumin53 Alclofenac54 Alclometasone; except when specified elsewhere in this schedule55 Alcohol; for injection in medicines containing more than 20%56 Alcuronium57 Aldesleukin

Schedule Medicines Amendment Regulations 2018 2018/179

4

58 Aldosterone; except in medicines containing 10 micrograms or less per litre orper kilogram

59 Alectinib60 Alefacept61 Alemtuzumab62 Alendronic acid63 Alfacalcidol64 Alfentanil65 Alfuzosin66 Alglucerase67 Alglucosidase68 Alirocumab69 Aliskiren70 Alkyl sulfonals71 Allergens72 Allopurinol73 Allylisopropylacetylurea; at all strengths74 Allyloestrenol75 Alogliptin76 Aloracetam77 Alosetron78 Alpha1-proteinase inhibitor79 Alphadolone80 Alphaxalone81 Alprazolam82 Alprenolol83 Alprostadil84 Alseroxylon85 Alteplase86 Altretamine87 Amantadine88 Ambenonium89 Ambrisentan90 Ambucetamide91 Ambutonium


5

92 Amcinonide93 Amethocaine; except when specified elsewhere in this schedule; for ophthal-

mic use except when used in practice by an optometrist registered with theOptometrists and Dispensing Opticians Board

94 Amfebutamone95 Amfepramone96 Amidopyrine97 Amifampridine98 Amifostine99 Amikacin100 Amiloride101 Aminocaproic acid102 Aminoglutethimide103 Aminometradine104 Aminophenazone; at all strengths105 Aminophylline; except when specified elsewhere in this schedule106 Aminopterin107 Aminorex108 Aminosalicylic acid109 Amiodarone110 Amiphenazole111 Amisometradine112 Amisulpride113 Amitriptyline114 Amlodipine115 Ammi visnaga116 Ammonium bromide117 Amobarbital118 Amodiaquine119 Amorolfine; except when specified elsewhere in this schedule; except in prep-

arations for the treatment of tinea pedis only or when sold in practice by apodiatrist registered with the Podiatrists Board

120 Amoxapine121 Amoxycillin122 Amphomycin


6

123 Amphotericin124 Ampicillin125 Amprenavir126 Amrinone127 Amsacrine128 Amygdalin; at all strengths129 Amyl nitrite; except when sold to a person who is appropriately authorised

under the Health and Safety at Work Act 2015130 Amylocaine131 Anabolic steroids132 Anagrelide133 Anakinra134 Anastrozole135 Ancestim136 Anchusa officinalis; at all strengths137 Ancrod and its immunoglobulin antidote138 Androgenic and anabolic steroidal agents139 Androgens140 Androisoxazole141 Androstanolone142 Androstenediol143 Androstenedione144 Anecortave145 Angiotensinamide146 Anidulafungin147 Aniracetam148 Anistreplase149 Antazoline; except for ophthalmic use150 Antibiotic substances; except when specified elsewhere in this schedule151 Antigens152 Antihistamines; except when specified elsewhere in this schedule153 Antimony; except in medicines containing 1 milligram or less per litre or per

kilogram154 Antisera; for injection155 AOD-9604


7

156 Apalutamide157 Apixaban158 Apocynum spp159 Apomorphine; except in medicines containing 1 milligram or less per litre or

per kilogram160 Apraclonidine161 Apremilast162 Aprepitant163 Apronal164 Aprotinin165 Arecoline166 Aripiprazole167 Aristolochia spp; at all strengths168 Aristolochic acid; at all strengths169 Armodafinil170 Arsenic; except in medicines containing 1 milligram or less per litre or per

kilogram171 Artemether172 Artesunate173 Articaine; except when used as a local anaesthetic in practice by a dental thera-

pist or oral health therapist registered with the Dental Council174 Asenapine175 Asfotase alfa176 Asparaginase177 Aspirin; except when specified elsewhere in this schedule; for injection; when

combined with caffeine, paracetamol, or salicylamide178 Astemizole179 Asunaprevir180 Atamestane181 Atazanavir182 Atenolol183 Atezolizumab184 Atomoxetine185 Atorvastatin186 Atosiban


8

187 Atovaquone188 Atracurium189 Atropa belladonna; except when specified elsewhere in this schedule; except in

medicines containing 300 micrograms or less of total solanaceous alkaloids perlitre or per kilogram

190 Atropine; except when specified elsewhere in this schedule; except when usedas an antidote in a device designed for self-injection; except in medicines con-taining 300 micrograms or less per litre or per kilogram

191 Atropine methonitrate192 Auranofin193 Aurothiomalate sodium194 Avanafil195 Aviptadil196 Axitinib197 Azacitidine198 Azacyclonol199 Azapropazone200 Azaribine201 Azatadine; except when specified elsewhere in this schedule202 Azathioprine203 Azelaic acid; except when specified elsewhere in this schedule204 Azelastine; except when specified elsewhere in this schedule205 Azithromycin206 Azlocillin207 Aztreonam208 Bacampicillin209 Bacitracin210 Baclofen211 Balsalazide212 Bambuterol213 Bamethan214 Bamipine215 Barbital216 Barbiturates217 Basiliximab


9

218 Bazedoxifene219 Becaplermin220 Beclamide221 Beclomethasone; except when specified elsewhere in this schedule222 Bedaquiline223 Belatacept224 Belimumab225 Bemegride226 Benactyzine227 Benazepril228 Bendamustine229 Bendrofluazide230 Benethamine penicillin231 Benorylate232 Benoxaprofen233 Benperidol234 Benserazide235 Benzathine penicillin236 Benzatropine237 Benzbromarone238 Benzhexol239 Benzilonium240 Benzocaine; except when specified elsewhere in this schedule241 Benzodiazepine derivatives; except when specified elsewhere in this schedule242 Benzodiazepines; except when specified elsewhere in this schedule243 Benzoyl metronidazole244 Benzoyl peroxide; except when specified elsewhere in this schedule245 Benzthiazide246 Benzydamine; except when specified elsewhere in this schedule247 Benzylpenicillin248 Bepridil249 Beractant250 Besifloxacin251 Beta carotene; in medicines containing more than 18 milligrams per recom-

mended daily dose


10

252 Betahistine253 Betaine; for the treatment of homocystinuria254 Betamethasone255 Betaxolol256 Bethanechol257 Bethanidine258 Bevacizumab259 Bevantolol260 Bexarotene261 Bezafibrate262 Bezlotoxumab263 Bicalutamide264 Bictegravir265 Bifonazole; except when specified elsewhere in this schedule266 Bilastine; except when specified elsewhere in this schedule267 Bimatoprost268 Binimetinib269 Biperiden270 Bismuth; except for external use in medicines containing 3% or less271 Bisoprolol272 Bithionol; at all strengths273 Bivalirudin274 Bleomycin275 Boceprevir276 Bolandiol277 Bolasterone278 Bolazine279 Boldenone280 Bolenol281 Bolmantalate282 Boron, including borax and boric acid; except in medicines for internal use

containing 6 milligrams or less per recommended daily dose; except in medi-cines for dermal use other than paediatric use containing 0.35% or less; exceptwhen present as an excipient

283 Bortezomib


11

284 Bosentan285 Bosutinib286 Botulinum toxins287 Brentuximab vedotin288 Bretylium289 Brexpiprazole290 Brimonidine291 Brinzolamide292 Brivaracetam (and its stereoisomers)293 Bromazepam294 Bromocriptine295 Bromoform296 Brompheniramine; except when specified elsewhere in this schedule297 Bromvaletone298 Brotizolam299 Brugmansia spp300 Buclizine; except for oral use301 Budesonide; except when specified elsewhere in this schedule302 Bufexamac; except in suppositories; except for dermal use in medicines con-

taining 5% or less303 Bumetanide304 Buniodyl sodium; at all strengths305 Buphenine306 Bupivacaine307 Buprenorphine308 Bupropion309 Buserelin310 Buspirone311 Busulphan312 Butacaine313 Butobarbital314 Butoconazole; except for vaginal use315 Butorphanol316 Butyl aminobenzoate; except in medicines for dermal use containing 2% or

less


12

317 Butyl nitrite318 Butylchloral hydrate319 Cabazitaxel320 Cabergoline321 Cabozantinib322 Cacalia spp; at all strengths323 Cadmium324 Calcipotriol; except in medicines containing not more than 50 micrograms per

gram or per millilitre and when sold in a pack of not more than 30 grams or 30millilitres by a pharmacist to an adult with mild to moderate psoriasis previ-ously diagnosed by a doctor

325 Calcitonin326 Calcitriol327 Calcium carbimide328 Calcium polystyrene sulphonate329 Calotropis gigantea330 Calotropis procera331 Calusterone332 Camazepam333 Camphorated oil334 Camphotamide335 Canagliflozin336 Canakinumab337 Candesartan338 Candicidin339 Cannabidiol340 Capecitabine341 Capreomycin342 Captodiame343 Captopril344 Capuride345 Caramiphen346 Carbachol347 Carbamazepine348 Carbaryl; except for external use in medicines containing 2% or less


13

349 Carbazochrome350 Carbenicillin351 Carbenoxolone; except for external use352 Carbetocin353 Carbidopa354 Carbimazole355 Carbocromen356 Carboplatin357 Carboprost358 Carbromal359 Carbutamide360 Carbuterol361 Carfilzomib362 Carglumic acid363 Carindacillin364 Carisoprodol365 Carmustine366 Carprofen367 Carvedilol368 Caspofungin369 Catumaxomab370 Cebaracetam (and its stereoisomers)371 Cefacetrile372 Cefaclor373 Cefaloridine374 Cefamandole375 Cefapirin376 Cefazolin377 Cefepime378 Cefetamet379 Cefixime380 Cefodizime381 Cefonicid382 Cefoperazone383 Cefotaxime


14

384 Cefotetan385 Cefotiam386 Cefoxitin387 Cefpirome388 Cefpodoxime389 Cefsulodin390 Ceftaroline fosamil391 Ceftazidime392 Ceftibuten393 Ceftolozane394 Ceftriaxone395 Cefuroxime396 Celecoxib397 Celiprolol398 Cephaelis acuminata; except in medicines containing less than 0.2% of emetine399 Cephaelis ipecacuanha; except in medicines containing less than 0.2% of emet-

ine400 Cephalexin401 Cephalothin402 Cephradine403 Ceritinib404 Cerivastatin405 Certolizumab pegol406 Ceruletide407 Cetirizine; except when specified elsewhere in this schedule408 Cetrorelix409 Cetuximab410 Chenodeoxycholic acid411 Chloral hydrate; except for dermal use in medicines containing 2% or less412 Chloralformamide413 Chloralose414 Chlorambucil415 Chloramphenicol; except when sold in practice by an optometrist registered

with the Optometrists and Dispensing Opticians Board; except when specifiedelsewhere in this schedule


15

416 Chlorandrostenolone417 Chlorazanil418 Chlorcyclizine419 Chlordiazepoxide420 Chlormerodrin421 Chlormethiazole422 Chlormezanone423 Chloroform; for anaesthesia; except when specified elsewhere in this schedule424 Chloroquine425 Chlorothiazide426 Chlorotrianisene427 Chloroxydienone428 Chloroxymesterone429 Chlorpheniramine; except when specified elsewhere in this schedule430 Chlorphentermine431 Chlorpromazine432 Chlorpropamide433 Chlorprothixene434 Chlorquinaldol435 Chlortetracycline436 Chlorthalidone437 Chlorzoxazone438 Cholera vaccine; except in the form of an oral liquid containing vibrio cholerae

when sold in a pharmacy by a registered pharmacist439 Cholic acid440 Choline salicylate; except in medicines containing 10% or less and in pack

sizes of 15 grams or less441 Chorionic gonadotrophin; except in pregnancy test kits442 Chymopapain443 Ciclacillin444 Ciclesonide445 Ciclopirox; except when specified elsewhere in this schedule446 Cidofovir447 Cilastatin448 Cilazapril


16

449 Cilostazol450 Cimetidine; except when specified elsewhere in this schedule451 Cinacalcet452 Cinchocaine; for injection; for ophthalmic use; for external use in medicines

containing more than 0.5%453 Cinchophen454 Cinnarizine455 Cinoxacin456 Ciprofloxacin457 Cisapride458 Cisatracurium459 Cisplatin460 Citalopram461 CJC-1295462 Cladribine463 Clarithromycin464 Clavulanic acid465 Clemastine; except for oral use466 Clemizole467 Clenbuterol468 Clevidipine469 Clidinium470 Clindamycin471 Clioquinol; at all strengths472 Clobazam473 Clobetasol474 Clobetasone; except when specified elsewhere in this schedule475 Clocortolone476 Clodronic acid477 Clofarabine478 Clofazimine479 Clofenamide480 Clofibrate481 Clomiphene482 Clomipramine


17

483 Clomocycline484 Clonazepam485 Clonidine486 Clopamide487 Clopidogrel488 Clorazepic acid489 Clorexolone490 Clorprenaline491 Clostebol492 Clotiazepam493 Clotrimazole; except when specified elsewhere in this schedule494 Cloxacillin495 Cloxazolam496 Clozapine497 Cobalt498 Cobicistat499 Cobimetinib500 Cocaine; except when specified elsewhere in this schedule501 Codeine; except when specified elsewhere in this schedule502 Co-dergocrine503 Colaspase504 Colchicine505 Colchicum506 Colecalciferol; except in medicines containing 25 micrograms or less per rec-

ommended daily dose; except in parenteral nutrition replacement preparations507 Colestipol508 Colestyramine509 Colfosceril510 Colistin511 Collagen; in injections or implants for tissue augmentation or cosmetic use512 Collagenase clostridium histolyticum513 Coluracetam514 Conium maculatum; at all strengths515 Convallaria keiski516 Convallaria majalis


18

517 Corifollitropin alfa518 Coronilla spp519 Corticosterone520 Corticotrophin521 Cortisone and other steroidal hormones of the adrenal cortex; except when spe-

cified elsewhere in this schedule; except adrenal extract for dermal use in med-icines containing 0.02% or less of ketosteroids

522 Cotarnine; at all strengths523 Co-trimoxazole524 Coumarin525 Crizotinib526 Crofelemer527 Crotalaria spp; at all strengths528 Croton tiglium; except in medicines containing 1 milligram or less per litre or

per kilogram529 Crystal violet530 Curare531 Cyclandelate532 Cyclizine; except when specified elsewhere in this schedule533 Cyclobenzaprine534 Cyclofenil535 Cycloheximide536 Cyclopenthiazide537 Cyclopentolate; except when used in practice by an optometrist registered with

the Optometrists and Dispensing Opticians Board538 Cyclophosphamide539 Cyclopropane540 Cycloserine541 Cyclosporin542 Cyclothiazide543 Cycrimine544 Cymarin545 Cynoglossum spp; at all strengths546 Cyproheptadine; except for oral use547 Cyproterone


19

548 Cysteamine549 Cytarabine550 Dabigatran551 Dabrafenib mesilate552 Dacarbazine553 Daclatasvir554 Daclizumab555 Dactinomycin556 Dalfopristin557 Dalteparin558 Danaparoid559 Danazol560 Danthron561 Dantrolene562 Dapagliflozin563 Dapoxetine564 Dapsone565 Daptomycin566 Daratumumab567 Darbepoetin568 Darifenacin569 Darunavir570 Dasabuvir571 Dasatinib572 Datura spp; except for oral use when specified elsewhere in this schedule;

except datura stramonium or datura tatula for smoking or burning573 Daunorubicin574 Deanol575 Debrisoquine576 Decamethonium577 Deferasirox578 Deferiprone579 Defibrotide580 Deflazacort581 Degarelix


20

582 Dehydrochloromethyltestosterone583 Dehydrocorticosterone584 Delavirdine585 Delorazepam586 Demecarium587 Demeclocycline588 Denosumab589 Deoxycortone590 Deoxycholic acid; for injection; except for oral use591 Deoxyribonuclease; except for external use592 Dermatophagoides farina allergen extract593 Dermatophagoides pteronyssinus allergen extract594 Desferrioxamine595 Desflurane596 Desipramine597 Desirudin598 Deslanoside599 Desloratadine; except for oral use600 Deslorelin601 Desmopressin602 Desogestrel; except when supplied for oral contraception to women who meet

the clinical and eligbility criteria of the Pharmacy Council and the Pharmaceut-ical Society of New Zealand Incorporated approved training programme onoral contraception, when sold in the manufacturer’s original pack that hasreceived the consent of the Minister or Director-General to their distribution asmedicines, containing not more than 6 months’ supply by a registered pharma-cist who has successfully completed the approved training programme

603 Desonide604 Desoximetasone605 Desvenlafaxine606 Dexamethasone607 Dexamfetamine608 Dexchlorpheniramine; except when specified elsewhere in this schedule609 Dexfenfluramine610 Dexmedetomidine611 Dextromethorphan; except when specified elsewhere in this schedule


21

612 Dextromoramide613 Dextropropoxyphene614 Dextrorphan615 Di-iodohydroxy quinoline; except when specified elsewhere in this schedule616 Di-isopropylamine dichloroacetate617 Diazepam618 Diazoxide619 Dibenzepin620 Dibotermin621 Dibrompropamidine; except for ophthalmic use622 Dichloralphenazone623 Dichlorophen624 Dichlorphenamide625 Diclofenac; in preparations for the treatment of solar keratosis; except when

specified elsewhere in this schedule; except in preparations for topical useother than for the treatment of solar keratosis

626 Dicloxacillin627 Dicyclomine628 Didanosine629 Dienoestrol630 Dienogest631 Diethazine632 Diethylcarbamazine633 Diethylstilbestrol634 Diflorasone635 Diflucortolone636 Diflunisal637 Digitalis lanata638 Digitalis purpurea639 Digitoxin640 Digoxin641 Digoxin-specific antibody fragment642 Dihydralazine643 Dihydrocodeine644 Dihydroergotoxine


22

645 Dihydrolone646 Dihydrotachysterol647 Diltiazem648 Dimenhydrinate; except when specified elsewhere in this schedule649 Dimercaprol650 Dimethandrostanolone651 Dimethazine652 Dimethindene; except for oral use653 Dimethothiazine654 Dimethoxanate655 Dimethyl fumarate656 Dimethyl sulphoxide657 Dimiracetam (and its stereoisomers)658 Dinitrocresols659 Dinitronaphthols660 Dinitrophenols661 Dinitrothymols662 Dinoprost663 Dinoprostone664 Diperodon665 Diphemanil; except for dermal use666 Diphenhydramine; except when specified elsewhere in this schedule667 Diphenidol668 Diphenoxylate; except when specified elsewhere in this schedule669 Diphenylpyraline670 Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when

administered in a single dose to a person 18 years of age or over or to a preg-nant woman aged 13 years or over by a registered pharmacist who has success-fully completed a vaccinator training course approved by the Ministry ofHealth and who is complying with the immunisation standards of the Ministryof Health

671 Diphtheria toxoid672 Diphtheria vaccine673 Dipivefrin674 Dipyridamole675 Dirithromycin


23

676 Disopyramide677 Distigmine678 Disulfiram679 Disulphamide680 Ditiocarb681 Dobutamine682 Docetaxel683 Dofetilide684 Dolasetron685 Doliracetam (and its stereoisomers)686 Dolutegravir687 Domperidone688 Donepezil689 Dopamine690 Dopexamine691 Doripenem692 Dornase693 Dorzolamide694 Dothiepin695 Doxantrazole696 Doxapram697 Doxazosin698 Doxepin699 Doxorubicin700 Doxycycline701 Doxylamine; except when specified elsewhere in this schedule702 Dronedarone703 Droperidol704 Drospirenone705 Drostanolone706 Drotrecogin707 Duboisia leichhardtii; except when specified elsewhere in this schedule708 Duboisia myoporides; except when specified elsewhere in this schedule709 Dulcin; at all strengths710 Duloxetine


24

711 Dupilumab712 Dupracetam713 Dutasteride714 Dydrogesterone715 Econazole; except when specified elsewhere in this schedule716 Ecothiopate717 Ectylurea718 Eculizumab719 Edetic acid; except in medicines containing 0.25% or less; except in contact

lens preparations; except dicobalt edetate for the treatment of cyanide poison-ing

720 Edoxudine721 Edrophonium722 Efalizumab723 Efavirenz724 Eflornithine725 Elbasvir726 Eletriptan727 Elosulfase alfa728 Elotuzumab729 Eltrombopag olamine730 Eluxadoline731 Elvitegravir732 Emepronium733 Emetine; except in medicines containing 0.2% or less734 Emicizumab735 Empagliflozin736 Emtricitabine737 Enalapril738 Encorafenib739 Enestebol740 Enflurane741 Enfuvirtide742 Enobosarm743 Enoxacin


25

744 Enoxaparin745 Enoximone746 Enprostil747 Entacapone748 Entecavir749 Enzalutamide750 Ephedrine751 Epicillin752 Epinastine753 Epirubicin754 Epitiostanol755 Eplerenone756 Epoetins757 Epoprostenol758 Eprosartan759 Eptifibatide760 Erenumab761 Ergocalciferol; except in medicines containing 25 micrograms or less per rec-

ommended daily dose762 Ergometrine763 Ergot764 Ergotamine765 Ergotoxine766 Eribulin767 Erlotinib768 Ertapenem769 Ertugliflozin770 Erysimum spp; except in medicines containing 1 milligram or less per litre or

per kilogram771 Erythromycin772 Erythropoietin773 Escitalopram774 Esmolol775 Esomeprazole; except when specified elsewhere in this schedule776 Estazolam


26

777 Estramustine778 Estropipate779 Etanercept780 Ethacrynic acid781 Ethambutol782 Ethamivan783 Ethanolamine; for injection784 Ethchlorvynol785 Ether; for anaesthesia; except when specified elsewhere in this schedule786 Ethinamate787 Ethinyloestradiol; except when supplied at a strength of 35 micrograms or less

in combination with either levonorgestrel or norethisterone for oral contracep-tion to women who meet the clinical and eligibility criteria of the PharmacyCouncil and the Pharmaceutical Society of New Zealand Incorporatedapproved training programme on oral contraception, when sold in the manufac-turer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’supply by a registered pharmacist who has successfully completed theapproved trainining programme

788 Ethionamide789 Ethisterone790 Ethoglucid791 Ethoheptazine792 Ethopropazine793 Ethosuximide794 Ethotoin795 Ethoxzolamide796 Ethyl chloride; for inhalation797 Ethyl loflazepate798 Ethyldienolone799 Ethylhexanediol; at all strengths800 Ethyloestrenol801 Ethynodiol802 Etidocaine803 Etidronic acid; except in medicines for external use containing 1% or less804 Etilefrine


27

805 Etiracetam806 Etodolac807 Etofenamate; except for external use808 Etomidate809 Etonogestrel810 Etoposide811 Etoricoxib812 Etravirine813 Etretinate814 Everolimus815 Evolocumab816 Exemestane817 Exenatide818 Ezetimibe819 Factor VIII inhibitor bypassing fraction820 Famciclovir; except when specified elsewhere in this schedule821 Famotidine; except when specified elsewhere in this schedule822 Fampridine823 Farfugium japonicum; at all strengths824 Fasoracetam (and its stereoisomers)825 Febuxostat826 Felbamate827 Felbinac; except for external use828 Felodipine829 Felypressin; except when combined with a local anaesthetic and used in prac-

tice by a dental therapist or oral health therapist registered with the DentalCouncil

830 Fenbufen831 Fenclofenac832 Fenfluramine833 Fenofibrate834 Fenoldopam835 Fenoprofen836 Fenoterol837 Fenpipramide


28

838 Fenpiprane839 Fentanyl840 Ferric carboxymaltose841 Ferric derisomaltose842 Fexofenadine; except when specified elsewhere in this schedule843 Fibrin844 Fibrinolysin; except for external use845 Fibroblast growth factor846 Fidaxomicin847 Filgrastim848 Finasteride849 Fingolimod850 Flecainide851 Fleroxacin852 Floctafenine853 Fluanisone854 Flubromazolam855 Fluclorolone856 Flucloxacillin857 Fluconazole; except when specified elsewhere in this schedule858 Flucytosine859 Fludarabine860 Fludiazepam861 Fludrocortisone862 Flufenamic acid863 Flumazenil864 Flumethasone865 Flumethiazide866 Flunarizine867 Flunisolide868 Flunitrazepam869 Fluocinolone870 Fluocinonide871 Fluocortin872 Fluocortolone


29

873 Fluorescein; for injection874 Fluorides; for internal use in medicines containing more than 0.5 milligrams

per dose unit except in medicines containing 15 milligrams or less per litre orper kilogram; except in parenteral nutrition replacement preparations; for exter-nal use in medicines containing more than 5.5 grams per litre or per kilogramexcept when supplied to a dental professional registered with the Dental Coun-cil

875 Fluorometholone876 Fluorouracil877 Fluoxetine878 Fluoxymesterone879 Flupenthixol880 Fluphenazine881 Flurandrenolone882 Flurazepam883 Flurbiprofen; except when specified elsewhere in this schedule884 Fluroxene885 Fluspirilene886 Flutamide887 Fluticasone; except when specified elsewhere in this schedule888 Fluvastatin889 Fluvoxamine890 Folic acid; except when specified elsewhere in this schedule891 Folinic acid; except when specified elsewhere in this schedule892 Follicle-stimulating hormone; except in medicines containing 100 micrograms

or less per litre or per kilogram893 Follistatin894 Follitropin895 Follitropin delta896 Fomepizole897 Fomivirsen898 Fondaparinux899 Fonturacetam (and its stereoisomers)900 Formebolone901 Formestane902 Formoterol


30

903 Fosamprenavir904 Fosaprepitant905 Foscarnet906 Fosfestrol907 Fosfomycin908 Fosinopril909 Fosphenytoin910 Fotemustine911 Framycetin912 Fulvestrant913 Furaltadone914 Furazabol915 Furazolidone916 Furosemide917 Fusidic acid918 Gabapentin919 Galantamine920 Galanthus spp921 Gallamine922 Galsulfase923 Ganciclovir924 Ganirelix925 Gatifloxacin926 Gefitinib927 Gemcitabine928 Gemeprost929 Gemfibrozil930 Gemifloxacin931 Gemtuzumab ozogamicin932 Gentamicin933 Gestodene934 Gestonorone935 Gestrinone936 Ghrelin937 Gitalin


31

938 Glatiramer acetate939 Glecaprevir940 Glibenclamide941 Glibornuride942 Gliclazide943 Glimepiride944 Glipizide945 Glisoxepide946 Glutathione; for injection947 Glyceryl trinitrate; for injection; for transdermal use; except in medicines con-

taining 100 micrograms or less per litre or per kilogram948 Glycopyrronium949 Glymidine950 Golimumab951 Gonadorelin952 Gonadotrophic hormones; except when specified elsewhere in this schedule953 Goserelin954 Gramicidin955 Granisetron956 Grazoprevir957 Grepafloxacin958 Griseofulvin959 Growth hormone releasing hormones960 Growth hormone releasing peptide-6961 Growth hormone releasing peptides962 Guaifenesin; except when specified elsewhere in this schedule963 Guanabenz964 Guanethidine965 Guanfacine966 Guanidine967 Guselkumab968 Hachimycin969 Haematin970 Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of

bacterial complications of colds


32

971 Halazepam972 Halcinonide973 Halofantrine974 Halofenate975 Haloperidol; except in medicines containing 1 milligram or less per litre or per

kilogram976 Halothane977 Haloxazolam978 Halquinol; except for external use979 Heliotropium spp; at all strengths980 Hemerocallis981 Heparins; except when present as an excipient; except for external use982 Hepatitis A vaccine983 Hepatitis B vaccine984 Hetacillin985 Hexachlorophane; in medicines containing more than 3%; except when speci-

fied elsewhere in this schedule986 Hexamethonium987 Hexarelin988 Hexetidine; except for external use989 Hexobendine990 Hexocyclium991 Hexoprenaline992 Hexaminolevulinate993 Histamine; except in medicines containing 0.5% or less994 Homatropine995 Human chorionic gonadotrophin; except in pregnancy test kits996 Human growth hormone secretagogues997 Human papillomavirus vaccine998 Human protein C999 Hyaluronic acid; in injections or implants for tissue augmentation or cosmetic

use1000 Hydralazine1001 Hydrargaphen1002 Hydrochlorothiazide


33

1003 Hydrocortisone; except when specified elsewhere in this schedule1004 Hydrocyanic acid; except when specified elsewhere in this schedule1005 Hydroflumethiazide1006 Hydromorphone1007 Hydroquinone; except when specified elsewhere in this schedule1008 Hydroxychloroquine1009 Hydroxyephedrine1010 Hydroxyphenamate1011 Hydroxyprogesterone1012 Hydroxystenozol1013 Hydroxyurea1014 Hydroxyzine1015 Hylan polymer; in injections or implants for tissue augmentation or cosmetic

use1016 Hyoscine; except when specified elsewhere in this schedule; except in medi-

cines containing 300 micrograms or less per litre or per kilogram1017 Hyoscine butylbromide; except when specified elsewhere in this schedule1018 Hyoscyamine; except when specified elsewhere in this schedule; except in

medicines containing 300 micrograms or less per litre or per kilogram1019 Hyoscyamus niger; except when specified elsewhere in this schedule1020 Hypothalamic releasing factors1021 Hypromellose; for injection; except in intraocular viscoelastic products1022 Ibandronic acid1023 Ibogaine1024 Ibritumomab tiuxetan1025 Ibrutinib1026 Ibufenac1027 Ibuprofen; except when specified elsewhere in this schedule1028 Ibuterol1029 Ibutilide1030 Icatibant1031 Idarubicin1032 Idarucizumab1033 Idebenone1034 Idelalisib


34

1035 Idoxuridine; except for dermal use in medicines containing 0.5% or less1036 Idursulfase1037 Ifosfamide1038 Iloprost1039 Imatinib1040 Imiglucerase1041 Imipenem1042 Imipramine1043 Imiquimod1044 Immunoglobulins1045 Imuracetam1046 Indacaterol1047 Indapamide1048 Indinavir1049 Indomethacin; except when specified elsewhere in this schedule1050 Indoprofen1051 Indoramin1052 Infliximab1053 Influenza and coryza vaccines; for injection; for nasal use1054 Influenza vaccine; except when administered to a person 13 years of age or

over by a registered pharmacist who has successfully completed a vaccinatortraining course approved by the Ministry of Health and who is complying withthe immunisation standards of the Ministry of Health

1055 Ingenol mebutate1056 Insulin degludec1057 Insulin-like growth factors; except when specified elsewhere in this schedule1058 Insulins1059 Interferons1060 Interleukins1061 Iodothiouracil1062 Ipamorelin1063 Ipecacuanha; except when specified elsewhere in this schedule1064 Ipilimumab1065 Ipratropium; except for nasal use1066 Ipriflavone


35

1067 Iprindole1068 Iproniazid1069 Irbesartan1070 Irinotecan1071 Iron; except when specified elsewhere in this schedule1072 Isoaminile1073 Isoamyl nitrite1074 Isobutyl nitrite1075 Isocarboxazid1076 Isoconazole; except when specified elsewhere in this schedule1077 Isoetarine1078 Isoflurane1079 Isometheptene1080 Isoniazid1081 Isoprenaline1082 Isoprinosine1083 Isopropamide; except when specified elsewhere in this schedule1084 Isosorbide dinitrate1085 Isosorbide mononitrate1086 Isotretinoin1087 Isoxicam1088 Isoxsuprine1089 Isradipine1090 Itraconazole1091 Ivabradine1092 Ivacaftor1093 Ivermectin1094 Ixabepilone1095 Ixazomib1096 Ixekizumab1097 Japanese encephalitis vaccine1098 Juniperus sabina; at all strengths1099 Kanamycin1100 Ketamine1101 Ketanserin


36

1102 Ketazolam1103 Ketoconazole; except when specified elsewhere in this schedule1104 Ketoprofen; except when specified elsewhere in this schedule1105 Ketorolac1106 Ketotifen; except for ophthalmic use in medicines containing 0.025% or less1107 Khellin1108 Labetalol1109 Lacidipine1110 Lacosamide1111 Lamivudine1112 Lamotrigine1113 Lanatosides1114 Lanreotide1115 Lansoprazole; except when specified elsewhere in this schedule1116 Lanthanum1117 Lapatinib1118 Laronidase-rch1119 Laropiprant1120 Latamoxef1121 Latanoprost1122 Laudexium1123 Lauromacrogols; for injection1124 Lead1125 Ledipasvir1126 Lefetamine1127 Leflunomide1128 Lenalidomide1129 Lenograstim1130 Lenvatinib1131 Lepirudin1132 Leptazol1133 Lercanidipine1134 Lesinurad1135 Letermovir1136 Letrozole


37

1137 Leucovorin; for injection1138 Leuprorelin1139 Levallorphan1140 Levamisole1141 Levetiracetam1142 Levobunolol1143 Levobupivacaine1144 Levocabastine; except for nasal or ophthalmic use1145 Levocetirizine; except for oral use1146 Levodopa1147 Levomepromazine1148 Levomilnacipran1149 Levonorgestrel; except when specified elsewhere in this schedule; except in

medicines for use as emergency post-coital contraception when sold by nursesrecognised by their professional body as having competency in the field of sex-ual and reproductive health; except when sold by nurses recognised by theirprofessional body as having competency in the field of sexual and reproductivehealth; except when supplied for oral contraception to women who meet theclinical and eligibility criteria of the Pharmacy Council and the PharmaceuticalSociety of New Zealand Incorporated approved training programme on oralcontraception, when sold in the manufacturer’s original pack that has receivedthe consent of the Minister or Director-General to their distribution as medi-cines, containing not more than 6 months’ supply by a registered pharmacistwho has successfully completed the approved training programme

1150 Levosimendan1151 Lidoflazine1152 Lidocaine; for injection except when used as a local anaesthetic in practice by a

nurse whose scope of practice permits the performance of general nursingfunctions or by a podiatrist registered with the Podiatrists Board or by a dentaltherapist or an oral health therapist registered with the Dental Council; for oph-thalmic use except when used in practice by an optometrist registered with theOptometrists and Dispensing Opticians Board; for oral use except in throat loz-enges containing 30 milligrams or less per dose form; for external use in medi-cines containing more than 10%; except in throat sprays in medicines contain-ing 2% or less; except when specified elsewhere in this schedule

1153 Ligularia dentata; at all strengths1154 Linagliptin1155 Lincomycin1156 Lindane; except for external use in medicines containing 2% or less


38

1157 Linezolid1158 Liothyronine1159 Lipegfilgrastim1160 Liraglutide1161 Lisdexamfetamine1162 Lisinopril1163 Lisuride1164 Lithium; except when specified elsewhere in this schedule; except when

present as an excipient in dermal medicines containing 0.25% or less1165 Lixisenatide1166 Lodoxamide; except in medicines for ophthalmic use1167 Lofexidine1168 Lomefloxacin1169 Lomustine1170 Loperamide; except when specified elsewhere in this schedule1171 Lopinavir1172 Loprazolam1173 Loracarbef1174 Loratadine; except when specified elsewhere in this schedule1175 Lorazepam1176 Lormetazepam1177 Losartan1178 Loteprednol1179 Lovastatin; except when present as an unmodified, naturally occurring sub-

stance in a food that has not been subject to a manufacturing process other thanheating, freezing, drying, preserving, bottling, canning, or packaging in retortpouches

1180 Loxapine1181 Lumacaftor1182 Lumefantrine1183 Lumiracoxib1184 Lurasidone1185 Luteinising hormone1186 Lymecycline1187 Macitentan


39

1188 Mafenide1189 Mannomustine1190 Maprotiline1191 Maraviroc1192 Mazindol1193 Measles vaccine1194 Mebanazine1195 Mebeverine1196 Mebhydrolin1197 Mebolazine1198 Mebutamate1199 Mecamylamine1200 Mecasermin1201 Mecillinam1202 Meclocycline1203 Meclofenamate1204 Meclofenoxate1205 Meclozine; except when specified elsewhere in this schedule1206 Medazepam1207 Medigoxin1208 Medroxyprogesterone1209 Medrysone1210 Mefenamic acid; except when specified elsewhere in this schedule1211 Mefloquine1212 Mefruside1213 Megestrol1214 Melagatran1215 Melanocyte stimulating compounds1216 Melatonin1217 Melengestrol1218 Melia azedarach; at all strengths1219 Meloxicam1220 Melphalan1221 Memantine


40

1222 Meningococcal vaccine; except when administered to a person 16 years of ageor over by a registered pharmacist who has successfully completed a vaccinatortraining course approved by the Ministry of Health and who is complying withthe immunisation standards of the Ministry of Health

1223 Menotrophin1224 Mepacrine1225 Mepenzolate1226 Mephenesin1227 Mephentermine1228 Mepindolol1229 Mepitiostane1230 Mepivacaine1231 Mepolizumab1232 Meprobamate1233 Meptazinol1234 Mepyramine; except when specified elsewhere in this schedule1235 Mequitazine1236 Mercaptomerin1237 Mercaptopurine1238 Mercurochrome; except when specified elsewhere in this schedule1239 Mercury; except when specified elsewhere in this schedule1240 Meropenem1241 Mersalyl1242 Mesabolone1243 Mesalazine1244 Mesna1245 Mestanolone1246 Mesterolone1247 Mestranol1248 Metamfetamine1249 Metandienone1250 Metaraminol1251 Metenolone1252 Metergoline1253 Metformin


41

1254 Methacholine1255 Methacycline1256 Methadone1257 Methallenoestril1258 Methandriol1259 Methanthelinium1260 Methazolamide1261 Methdilazine; except for oral use1262 Methicillin1263 Methimazole1264 Methisazone1265 Methixene1266 Methocarbamol1267 Methohexitone1268 Methoin1269 Methotrexate1270 Methoxamine; except when specified elsewhere in this schedule1271 Methoxsalen1272 Methoxyflurane1273 Methsuximide1274 Methyclothiazide1275 Methyl aminolevulinate1276 Methyl androstanolone1277 Methyl clostebol1278 Methyl mercury; except in medicines containing 300 micrograms or less per

litre or per kilogram1279 Methyl salicylate; except for external use; except for internal use when present

as an excipient in medicines containing 1.04% or less per dose form1280 Methyl trienolone1281 Methyldopa1282 Methylene blue; for injection1283 Methylergometrine1284 Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present

as an unmodified, naturally occurring substance1285 Methylnaltrexone


42

1286 Methylpentynol1287 Methylphenidate1288 Methylphenobarbital1289 Methylprednisolone1290 Methyltestosterone1291 Methylthiouracil1292 Methyprylon1293 Methysergide1294 Metoclopramide; except when specified elsewhere in this schedule1295 Metolazone1296 Metoprolol1297 Metribolone1298 Metrifonate1299 Metronidazole1300 Metyrapone1301 Mexiletine1302 Mezlocillin1303 Mianserin1304 Mibefradil1305 Mibolerone1306 Micafungin1307 Miconazole; except when specified elsewhere in this schedule1308 Midazolam1309 Midodrine1310 Mifepristone1311 Migalastat1312 Miglitol1313 Miglustat1314 Milnacipran1315 Milrinone1316 Minocycline1317 Minoxidil; except for dermal use in medicines containing 5% or less1318 Mirabegron1319 Mirtazapine1320 Misoprostol


43

1321 Mitobronitol1322 Mitomycin1323 Mitoxantrone1324 Mitragyna speciosa1325 Mitragynine1326 Mivacurium1327 Moclobemide1328 Modafinil1329 Molgramostim1330 Molindone1331 Molracetam1332 Mometasone; except when specified elsewhere in this schedule1333 Monobenzone1334 Monoclonal antibodies; except in pregnancy test kits1335 Montelukast1336 Moperone1337 Morazone1338 Moricizine1339 Morphine; except when specified elsewhere in this schedule1340 Motrazepam1341 Motretinide1342 Moxifloxacin1343 Mumps vaccine1344 Mupirocin1345 Muraglitazar1346 Muromonab1347 Mustine1348 Mycophenolic acid1349 Nabilone1350 Nabumetone1351 Nadolol1352 Nadroparin1353 Nafarelin1354 Naftidrofuryl1355 Nalbuphine


44

1356 Nalidixic acid1357 Nalmefene1358 Nalorphine1359 Naloxegol1360 Naloxone; except when provided as part of an approved emergency kit for the

treatment of opioid overdose1361 Naltrexone1362 Nandrolone1363 Naproxen; except when specified elsewhere in this schedule1364 Naratriptan1365 Natalizumab1366 Natamycin1367 Nateglinide1368 Nebacumab1369 Nebivolol1370 Nebracetam (and its stereoisomers)1371 Nedocromil1372 Nefazodone1373 Nefiracetam1374 Nefopam1375 Nelfinavir1376 Neomycin1377 Neostigmine1378 Nepafenac1379 Nepidermin1380 Nerium oleander1381 Nesiritide1382 Netilmicin1383 Netupitant1384 Nevirapine1385 Nialamide1386 Nicardipine1387 Nicergoline1388 Nicofuranose1389 Nicoracetam


45

1390 Nicorandil1391 Nicotine; except when specified elsewhere in the schedule; except in prepar-

ations for oromucosal or transdermal absorption; for nasal use except whensold from a smoking cessation clinic run under the auspices of a registeredmedical practitioner; in medicines other than for smoking cessation

1392 Nicotinic acid except nicotinamide; except when specified elsewhere in thisschedule

1393 Nicoumalone1394 Nifedipine1395 Nifenazone1396 Nikethamide1397 Nilotinib1398 Nilutamide1399 Nimesulide1400 Nimetazepam1401 Nimodipine1402 Nimorazole1403 Nintedanib1404 Niridazole1405 Nisoldipine1406 Nitazoxanide1407 Nitisinone1408 Nitrazepam1409 Nitrendipine1410 Nitric oxide1411 Nitrofurantoin1412 Nitrofurazone1413 Nitrous oxide; when supplied for inhalation1414 Nitroxoline1415 Nivolumab1416 Nizatidine; except when specified elsewhere in this schedule1417 Nomegestrol1418 Nomifensine1419 Noopept (and its stereoisomers)1420 Noradrenaline


46

1421 Norandrostenolone1422 Norbolethone1423 Norclostebol1424 Nordazepam1425 Norelgestromin1426 Norethandrolone1427 Norethisterone; except when supplied for oral contraception to women who

meet the clinical and eligibility criteria of the Pharmacy Council and thePharmaceutical Society of New Zealand Incorporated approved training pro-gramme on oral contraception, when sold in the manufacturer’s original packthat has received the consent of the Minister or Director-General to their distri-bution as medicines, containing not more than 6 months’ supply by a registeredpharmacist who has successfully completed the approved training programme

1428 Norfloxacin1429 Norgestrel1430 Noribogaine1431 Normethandrone1432 Nortriptyline1433 Noxiptyline1434 Nusinersen1435 Nux vomica; except in medicines containing 1 milligram or less per litre or per

kilogram of strychnine1436 Nystatin; except when specified elsewhere in this schedule1437 Obinutuzumab1438 Ocrelizumab1439 Ocriplasmin1440 Octamylamine1441 Octatropine1442 Octreotide1443 Octyl nitrite1444 Oestradiol; except in medicines containing 10 micrograms or less per litre or

per kilogram1445 Oestriol1446 Oestrogens1447 Oestrone; except in medicines containing 1 milligram or less per litre or per

kilogram1448 Ofatumumab


47

1449 Ofloxacin1450 Olanzapine1451 Olaparib1452 Oleandomycin1453 Oleandrin1454 Olmesartan1455 Olodaterol1456 Olopatadine1457 Olsalazine1458 Omalizumab1459 Ombitasvir1460 Omeprazole; except when specified elsewhere in this schedule1461 Ondansetron1462 Opipramol1463 Opium; except when specified elsewhere in this schedule1464 Orciprenaline1465 Orlistat; except in medicines for weight control containing 120 milligrams or

less per dose form1466 Ornidazole1467 Ornipressin1468 Orphenadrine1469 Orthopterin1470 Oseltamivir; except when specified elsewhere in this schedule1471 Osimertinib1472 Otilonium bromide1473 Ouabain1474 Ovandrotone1475 Oxabolone1476 Oxacillin1477 Oxaliplatin1478 Oxandrolone1479 Oxaprozin1480 Oxazepam1481 Oxazolam1482 Oxcarbazepine


48

1483 Oxedrine; except in medicines containing 30 milligrams or less per recommen-ded daily dose

1484 Oxetacaine; except for internal use1485 Oxiconazole; except when specified elsewhere in this schedule1486 Oxiracetam (and its stereoisomers)1487 Oxitropium1488 Oxolamine1489 Oxolinic acid1490 Oxpentifylline1491 Oxprenolol1492 Oxybuprocaine; except when used in practice by an optometrist registered with

the Optometrists and Dispensing Opticians Board1493 Oxybutynin1494 Oxycodone1495 Oxymesterone1496 Oxymetholone1497 Oxyphenbutazone1498 Oxyphencyclimine1499 Oxyphenisatin; at all strengths1500 Oxyphenonium1501 Oxytetracycline1502 Oxytocin; except in medicines containing 1 microgram or less per litre or per

kilogram1503 Paclitaxel1504 Palbociclib1505 Palifermin1506 Paliperidone1507 Palivizumab1508 Palonosetron1509 Pamaquin1510 Pamidronic acid1511 Pancreatic enzymes; except in medicines containing 20 000 BP units or less of

lipase activity1512 Pancuronium1513 Panitumumab


49

1514 Panobinostat1515 Pantoprazole; except when specified elsewhere in this schedule1516 Papaveretum1517 Papaverine; for injection1518 Paracetamol; except when specified elsewhere in this schedule1519 Paraldehyde1520 Paramethadione1521 Paramethasone1522 Parecoxib1523 Paricalcitol1524 Paritabprevir1525 Paromomycin1526 Paroxetine1527 Pasireotide1528 Patent blue V; for injection when used in diagnostic procedures1529 Patiromer sorbitex calcium1530 Pazopanib1531 Pecazine1532 Pefloxacin1533 Pegaptanib1534 Pegaspargase1535 Pegfilgrastim1536 Peginterferon1537 Peginterferon beta-1a1538 Pegvisomant1539 Pembrolizumab1540 Pemetrexed1541 Pemoline1542 Pempidine1543 Penbutolol1544 Penciclovir; except when specified elsewhere in this schedule1545 Penicillamine1546 Pentaerythrityl tetranitrate1547 Pentagastrin1548 Pentamethonium


50

1549 Pentamidine1550 Pentazocine1551 Penthienate1552 Pentolinium1553 Pentosan polysulfate sodium1554 Pentostatin1555 Pentoxifylline1556 Peramivir1557 Perampanel1558 Pergolide1559 Perhexiline1560 Pericyazine1561 Perindopril1562 Permethrin; except in medicines containing 5% or less1563 Perphenazine1564 Pertussis antigen1565 Pertussis (whooping cough) vaccine1566 Pertuzumab1567 Pethidine1568 Phenacemide1569 Phenacetin; except when present as an excipient1570 Phenaglycodol1571 Phenazone; except for external use1572 Phenazopyridine1573 Phenelzine1574 Pheneticillin1575 Phenformin1576 Phenglutarimide1577 Phenibut1578 Phenindione1579 Pheniramine; except when specified elsewhere in this schedule1580 Phenisatin1581 Phenobarbital1582 Phenol; for injection1583 Phenolphthalein


51

1584 Phenoperidine1585 Phenoxybenzamine1586 Phenoxymethylpenicillin1587 Phensuximide1588 Phentermine1589 Phenthimentonium1590 Phentolamine1591 Phenylbutazone1592 Phenylephrine; except when specified elsewhere in this schedule1593 Phenylpropanolamine1594 Phenyltoloxamine1595 Phenytoin1596 Phleum pratense extract1597 Pholcodine; except when specified elsewhere in this schedule1598 Phosphodiesterase type 5 inhibitors; except when present as an unmodified,

naturally occurring substance; except when specified elsewhere in this sched-ule

1599 Phthalylsulfathiazole1600 Physostigmine1601 Pibrentasvir1602 Picibanil1603 Picric acid1604 Picrotoxin1605 Pilocarpine; except in medicines containing 0.025% or less1606 Pimecrolimus1607 Pimozide1608 Pinacidil1609 Pinazepam1610 Pindolol1611 Pioglitazone1612 Pipecuronium1613 Pipemidic acid1614 Pipenzolate1615 Piperacetam1616 Piperacillin


52

1617 Piperidine1618 Piperidolate1619 Pipobroman1620 Pipothiazine1621 Pipradrol1622 Piracetam1623 Pirbuterol1624 Pirenoxine1625 Pirenzepine1626 Piretanide1627 Pirfenidone1628 Piroxicam; except for external use1629 Pirprofen1630 Pitavastatin1631 Pituitary hormones1632 Pivampicillin1633 Pizotifen1634 Plerixafor1635 Plicamycin1636 Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial

complications of colds1637 Podophyllotoxin; for internal use; for external use for the treatment of anogeni-

tal warts; for other external use in medicines containing more than 1%; exceptin medicines containing 1 milligram or less of podophyllin per litre or per kilo-gram

1638 Podophyllum emodi; for internal use; for external use for the treatment of ano-genital warts; for other external use in medicines containing more than 20% ofpodophyllin; except in medicines containing 1 milligram or less of podophyllinper litre or per kilogram

1639 Podophyllum peltatum; for internal use; for external use for the treatment ofanogenital warts; for other external use in medicines containing more than 20%of podophyllin; except in medicines containing 1 milligram or less of podo-phyllin per litre or per kilogram

1640 Polidexide1641 Poliomyelitis vaccine1642 Polyacrylamide; in injections or implants for tissue augmentation or cosmetic

use


53

1643 Polyestradiol1644 Polylactic acid; in injections or implants for tissue augmentation or cosmetic

use1645 Polymyxin1646 Polysulfated glycosaminoglycans; for injection except in intraocular viscoelas-

tic products1647 Polythiazide1648 Pomalidomide1649 Ponatinib1650 Poractant alfa1651 Posaconazole1652 Potassium bromide1653 Potassium perchlorate1654 Practolol1655 Pradofloxacin1656 Pralatrexate1657 Pralidoxime1658 Pralmorelin1659 Pramipexole1660 Pramiracetam1661 Pramocaine1662 Prampine1663 Prasterone1664 Prasugrel1665 Pravastatin1666 Prazepam1667 Praziquantel1668 Prazosin1669 Prednisolone1670 Prednisone1671 Pregabalin1672 Pregnenolone1673 Prenalterol1674 Prenylamine


54

1675 Prilocaine; for injection except when used as a local anaesthetic in practice bya dental therapist or an oral therapist registered with the Dental Council; exceptwhen specified elsewhere in this schedule

1676 Primaquine1677 Primidone1678 Probenecid1679 Probucol1680 Procainamide1681 Procaine1682 Procaine penicillin1683 Procarbazine1684 Prochlorperazine; except when specified elsewhere in this schedule; except

when sold for the treatment of nausea associated with emergency contraceptionby pharmacists or nurses accredited to sell levonorgestrel for emergency con-traception

1685 Procyclidine; except for dermal use in medicines containing 5% or less1686 Progesterone; except in medicines containing 1 milligram or less per litre or

per kilogram1687 Progestogens1688 Proglumide1689 Proguanil1690 Prolintane1691 Promazine1692 Promethazine; except when specified elsewhere in this schedule1693 Promoxolane1694 Propafenone1695 Propamidine; except for ophthalmic use1696 Propanidid1697 Propantheline1698 Propetandrol1699 Propionibacterium acnes1700 Propofol1701 Propranolol; except in medicines containing 1 milligram or less per litre or per

kilogram1702 Propylthiouracil1703 Propyphenazone


55

1704 Proquazone1705 Proscillaridin1706 Prostaglandins1707 Protamine1708 Prothionamide1709 Prothipendyl1710 Protirelin1711 Protoveratrines1712 Protriptyline1713 Proxymetacaine; except when used in practice by an optometrist registered

with the Optometrists and Dispensing Opticians Board1714 Prucalopride1715 Pseudoephedrine1716 Pulmonaria spp; at all strengths1717 Pyrazinamide1718 Pyridinolcarbamate1719 Pyridostigmine1720 Pyridoxal; except in medicines containing 200 milligrams or less per recom-

mended daily dose1721 Pyridoxamine; except in medicines containing 200 milligrams or less per rec-

ommended daily dose1722 Pyridoxine; except in medicines containing 200 milligrams or less per recom-

mended daily dose1723 Pyrimethamine1724 Pyrvinium1725 Quazepam1726 Quetiapine1727 Quinagolide1728 Quinapril1729 Quinbolone1730 Quinethazone1731 Quinidine1732 Quinine; except in medicines containing 50 milligrams or less per recommen-

ded daily dose1733 Quinisocaine1734 Quinupristin


56

1735 Rabeprazole1736 Rabies vaccine1737 Raloxifene1738 Raltegravir1739 Raltitrexed1740 Ramipril1741 Ramucirumab1742 Ranibizumab1743 Ranitidine; except when specified elsewhere in this schedule1744 Ranolazine1745 Rapacuronium1746 Rasagiline1747 Rasburicase1748 Rauwolfia serpentina1749 Rauwolfia vomitoria1750 Razoxane1751 Reboxetine1752 Recombinant human epidermal growth factor1753 Recombinant varicella zoster virus glycoprotein E antigen1754 Regorafenib1755 Remestemcel-L1756 Remifentanil1757 Remoxipride1758 Repaglinide1759 Reserpine1760 Reslizumab1761 Retapamulin1762 Reteplase1763 Retigabine1764 Ribavirin1765 Ribociclib1766 Ridaforolimus1767 Rifabutin1768 Rifampicin1769 Rifamycin


57

1770 Rifapentine1771 Rifaximin1772 Rilmazafone1773 Rilpivirine1774 Riluzole1775 Rimexolone1776 Rimiterol1777 Rimonabant1778 Riociguat1779 Risedronic acid1780 Risperidone1781 Ritodrine1782 Ritonavir1783 Rituximab1784 Rivaroxaban1785 Rivastigmine1786 Rizatriptan; except when specified elsewhere in this schedule1787 Rocuronium1788 Rofecoxib1789 Roflumilast1790 Rolipram (and its stereoisomers)1791 Rolitetracycline1792 Rolziracetam1793 Romidepsin1794 Romiplostim1795 Ropinirole1796 Ropivacaine1797 Rosiglitazone1798 Rosoxacin1799 Rosuvastatin1800 Rotavirus vaccine1801 Rotigotine1802 Roxibolone1803 Roxithromycin1804 Rubella vaccine


58

1805 Ruboxistaurin1806 Rufinamide1807 Rupatadine1808 Ruxolitnib1809 Sabadilla; except in preparations containing 10 milligrams or less of total alka-

loids of schoenocaulon officinale per litre or per kilogram1810 Sacubitril1811 Safrole; for internal use except in medicines containing 0.1% or less1812 Salbutamol1813 Salcatonin1814 Salmeterol1815 Sapropterin1816 Saquinavir1817 Sargramostim1818 Sarilumab1819 Saxagliptin1820 Schoenocaulon officinale; except in preparations containing 10 milligrams or

less of total alkaloids of schoenocaulon officinale per litre or per kilogram1821 Scopolia carniolica1822 Sebelipase alfa1823 Secbutabarbital1824 Secobarbital1825 Secukinumab1826 Selective androgen receptor modulators1827 Seletracetam (and its stereoisomers)1828 Selegiline1829 Selenium; except when specified elsewhere in this schedule; except for oral use

in medicines containing 150 micrograms or less per recommended daily dose1830 Selexipag1831 Serelaxin1832 Sermorelin1833 Sertindole1834 Sertraline1835 Serum, dried human1836 Sevelamer


59

1837 Sevoflurane1838 Sex hormones and all substances having sex hormone activity1839 Sialoepoetin1840 Sibutramine1841 Silandrone1842 Sildenafil and its structural analogues; except sildenafil in medicines for oral

use containing 100 milligrams or less per dose unit when sold in the manufac-turer’s original pack containing not more than 12 solid dosage units for thetreatment of erectile dysfunction in males aged 35–70 years by a registeredpharmacist who has successfully completed a training programme endorsed bythe Pharmaceutical Society of New Zealand Incorporated

1843 Silicones; for injection1844 Silodosin1845 Siltuximab1846 Silver sulfadiazine; except for external use in packs containing 50 grams or less1847 Simeprevir1848 Simvastatin1849 Sirolimus1850 Sisomicin1851 Sitagliptin1852 Sitaxentan1853 Sodium bromide1854 Sodium cellulose phosphate; for internal use1855 Sodium cromoglycate; except for nasal and ophthalmic use1856 Sodium morrhuate; for injection1857 Sodium nitroprusside1858 Sodium phenylbutyrate1859 Sodium phosphate; in oral laxative preparations1860 Sodium polystyrene sulphonate1861 Sodium tetradecyl sulphate; for injection1862 Sodium zirconium cyclosilicate1863 Sofosbuvir1864 Solasadine1865 Solifenacin1866 Somatostatin1867 Somatropin


60

1868 Sonidegib1869 Sontoquine1870 Sorafenib1871 Sotalol1872 Sparfloxacin1873 Sparteine1874 Spectinomycin1875 Spiramycin1876 Spirapril1877 Spironolactone1878 Stanolone1879 Stanozolol1880 Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of

bacterial complications of colds1881 Stavudine1882 Stenbolone1883 Steroid hormones1884 Stilboestrol1885 Stiripentol1886 Stramonium; except for oral use when specified elsewhere in this schedule;

except datura stramonium or datura tatula for smoking or burning1887 Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the pro-

phylaxis of bacterial complications of colds1888 Streptodornase1889 Streptokinase1890 Streptomycin1891 Streptozocin1892 Strontium ranelate1893 Strophanthins1894 Strophanthus spp1895 Strychnos spp; except in medicines containing 1 milligram or less per litre or

per kilogram of strychnine1896 Styramate1897 Succimer1898 Sufentanil


61

1899 Sugammadex1900 Sulbactam1901 Sulconazole; except for dermal use1902 Sulfacetamide; except for ophthalmic use in medicines containing 10% or less1903 Sulfadiazine; except silver sulfadiazine for external use in pack sizes of 50

grams or less1904 Sulfadimethoxine1905 Sulfadimidine1906 Sulfadoxine1907 Sulfafurazole1908 Sulfaguanidine1909 Sulfamerazine1910 Sulfamethizole1911 Sulfamethoxazole1912 Sulfamethoxydiazine1913 Sulfamethoxypyridazine1914 Sulfametrole1915 Sulfamonomethoxine1916 Sulfamoxole1917 Sulfaphenazole1918 Sulfapyridine1919 Sulfasalazine1920 Sulfathiazole1921 Sulfatroxazole1922 Sulfinpyrazone1923 Sulfomyxin1924 Sulfonmethane1925 Sulindac1926 Sultamicillin1927 Sulthiame1928 Sumatriptan; except when specified elsewhere in this schedule1929 Sunifiram1930 Sunitinib1931 Suprofen1932 Suvorexant


62

1933 Sutilains1934 Suxamethonium1935 Suxethonium1936 T cell receptor antibody1937 Tacrine1938 Tacrolimus1939 Tadalafil and its structural analogues1940 Tafenoquine succinate1941 Tafluprost1942 Taliglucerase alfa1943 Talimogene laherparepvec1944 Tamoxifen1945 Tamsulosin1946 Tanacetum vulgare; except in medicines containing 0.8% or less of oil of tansy1947 Tapentadol1948 Tasonermin1949 Tazarotene1950 Tazobactam1951 Teduglutide1952 Tegafur1953 Tegaserod1954 Teicoplanin1955 Telaprevir1956 Telbivudine1957 Telithromycin1958 Telmisartan1959 Telotristat ethyl1960 Temazepam1961 Temozolomide1962 Temsirolimus1963 Tenecteplase1964 Teniposide1965 Tenofovir1966 Tenoxicam1967 Terazosin


63

1968 Terbinafine; except when specified elsewhere in this schedule1969 Terbutaline1970 Terfenadine1971 Teriflunomide1972 Teriparatide1973 Terlipressin1974 Terodiline1975 Teropterin1976 Tesamorelin1977 Testolactone1978 Testosterone; except in medicines containing 1 milligram or less per litre or per

kilogram1979 Tetanus antitoxin1980 Tetanus toxoid1981 Tetanus vaccine1982 Tetrabenazine1983 Tetracosactrin1984 Tetracycline1985 Tetraethylammonium1986 Tetrahydrocannabinol1987 Tetrazepam1988 Tetroxoprim1989 Thalidomide1990 Thenyldiamine1991 Theophylline; except when specified elsewhere in this schedule1992 Thevetia peruviana1993 Thevetin1994 Thiambutosine1995 Thiazosulfone1996 Thiethylperazine1997 Thioacetazone1998 Thiocarlide1999 Thioguanine2000 Thiomesterone2001 Thiopentone


64

2002 Thiopropazate2003 Thioproperazine2004 Thioridazine2005 Thiotepa2006 Thiothixene2007 Thiouracil2008 Thiourea; except in medicines containing 0.1% or less2009 Thymosin beta-42010 Thymoxamine2011 Thyroid2012 Thyrotrophin2013 Thyrotrophin-releasing factor2014 Thyroxine; except in medicines containing 10 micrograms or less per litre or

per kilogram2015 Tiagabine2016 Tianeptine2017 Tiaprofenic acid2018 Tiaramide2019 Tibolone2020 Ticagrelor2021 Ticarcillin2022 Ticlopidine2023 Tiemonium2024 Tienilic acid2025 Tigecycline2026 Tigloidine2027 Tiletamine2028 Tilidine2029 Tiludronic acid2030 Timbetasin2031 Timolol2032 Tinidazole2033 Tinzaparin2034 Tioconazole; except when specified elsewhere in this schedule2035 Tiotropium


65

2036 Tipepidine2037 Tipiracil2038 Tiprinavir2039 Tirilazad2040 Tirofiban2041 Tizanidine2042 Tobramycin2043 Tocainide2044 Tocilizumab2045 Tofacitinib2046 Tolazamide2047 Tolazoline2048 Tolbutamide2049 Tolcapone2050 Tolfenamic acid2051 Tolmetin2052 Tolonium2053 Tolpropamine2054 Tolrestat2055 Tolterodine2056 Tolvaptan2057 Topiramate2058 Topotecan2059 Torasemide2060 Toremifene2061 Toxoids; for injection2062 Tramadol2063 Trametinib dimethyl sulfoxide2064 Trandolapril2065 Tranexamic acid2066 Tranylcypromine2067 Trastuzumab2068 Trastuzumab emtansine2069 Travoprost2070 Trazodone


66

2071 Trenbolone2072 Treosulphan2073 Treprostinil2074 Trestolone2075 Tretamine2076 Tretinoin2077 Triacetyloleandomycin2078 Triamcinolone; except when specified elsewhere in this schedule2079 Triamterene2080 Triaziquone2081 Triazolam2082 Trichlormethiazide2083 Trichloroacetic acid; except for external use in medicines containing 12.5% or

less for the treatment of warts other than anogenital warts2084 Trichloroethylene2085 Trichodesma africana; at all strengths2086 Triclofos2087 Tricyclamol2088 Tridihexethyl2089 Trientine2090 Trifluoperazine2091 Trifluperidol2092 Triflupromazine2093 Trifluridine2094 Trimeprazine; except when specified elsewhere in this schedule2095 Trimetaphan2096 Trimethoprim; except in medicines for oral use containing 300 milligrams or

less per dose unit when sold in a pack of 3 solid dosage units to a woman aged16–65 years for the treatment of an uncomplicated urinary tract infection by aregistered pharmacist who has successfully completed the New Zealand Col-lege of Pharmacists’ training in the treatment of urinary tract infections

2097 Trimipramine2098 Trimustine2099 Trinitrophenol2100 Trioxysalen2101 Triparanol; at all strengths


67

2102 Triple antigen vaccine2103 Triprolidine; except when specified elsewhere in this schedule2104 Triptorelin2105 Troglitazone2106 Trometamol; for injection in medicines containing more than 3%2107 Tropicamide; except when used in practice by an optometrist registered with

the Optometrists and Dispensing Opticians Board2108 Tropisetron2109 Trovafloxacin2110 Troxidone2111 Tryptophan; except in medicines containing 100 milligrams or less per recom-

mended daily dose; except in parenteral nutrition replacement preparations2112 Tuberculin2113 Tuberculosis vaccine2114 Tubocurarine2115 Tulobuterol2116 Typhoid vaccine2117 Ulipristal2118 Umeclidinium bromide2119 Unoprostone2120 Uracil2121 Urapidil2122 Urethane2123 Urofollitropin2124 Urokinase2125 Ursodeoxycholic acid2126 Ustekinumab2127 Vaccines; except when specified elsewhere in this schedule2128 Vaccinia virus vaccine2129 Valaciclovir2130 Valdecoxib2131 Valganciclovir2132 Valnoctamide2133 Valproic acid2134 Valsartan


68

2135 Vancomycin2136 Vandetanib2137 Vardenafil and its structural analogues2138 Varenicline2139 Varicella vaccine; except when administered for the prevention of herpes zoster

(shingles) to a person 50 years of age or over by a registered pharmacist whohas successfully completed a vaccinator training course approved by the Minis-try of Health and who is complying with the immunisation standards of theMinistry of Health

2140 Vasopressin2141 Vecuronium2142 Vedolizumab2143 Velaglucerase alfa2144 Velpatasvir2145 Vemurafenib2146 Venetoclax2147 Venlafaxine2148 Verapamil2149 Veratrum spp2150 Vernakalant2151 Verteporfin2152 Veruprevir2153 Vidarabine2154 Vigabatrin2155 Vilanterol2156 Vildagliptin2157 Viloxazine2158 Vinblastine2159 Vincamine2160 Vincristine2161 Vindesine2162 Vinflunine2163 Vinorelbine2164 Vinyl ether2165 Virginiamycin


69

2166 Vismodegib2167 Visnadine2168 Vitamin A; except for internal use in medicines containing 3 milligrams or less

of retinol equivalents per recommended daily dose; except in parenteral nutri-tion replacement preparations; except for external use in medicines containing1% or less

2169 Vitamin D; except for external use; except for internal use in medicines con-taining 25 micrograms or less per recommended daily dose; except in paren-teral nutrition replacement preparations

2170 Vorapaxar2171 Voriconazole2172 Vorinostat2173 Vortioxetine2174 Warfarin2175 Xamoterol2176 Xanthinol nicotinate2177 Ximelagatran2178 Xipamide2179 Yellow fever vaccine2180 Yohimbine2181 Zafirlukast2182 Zalcitabine2183 Zaleplon2184 Zanamivir2185 Zidovudine2186 Zimeldine2187 Zinc; except for internal use in medicines containing 25 milligrams or less per

recommended daily dose; except for internal use in medicines containing 50milligrams or less and more than 25 milligrams per recommended daily dose inpacks that have received the consent of the Minister or the Director-General totheir distribution as general sale medicines, when sold in the manufacturer’soriginal pack and when labelled with a statement that the product may be dan-gerous if taken in large amounts or for long periods; except for external usewhen in medicines containing 5% or less; except in parenteral nutritionreplacement preparations

2188 Ziprasidone2189 Zoledronic acid2190 Zolmitriptan; except when specified elsewhere in this schedule


70

2191 Zolpidem2192 Zonisamide2193 Zopiclone2194 Zoster immunoglobulin, human2195 Zoxazolamine2196 Zuclopenthixol

Part 2Restricted medicines

1 Adrenaline; in medicines containing 1% or less except in medicines for injec-tion containing 0.02% or less

2 Alclometasone; for dermal use in medicines containing 0.05% or less and inpacks containing not more than 30 grams that have received the consent of theMinister or the Director-General to their distribution as restricted medicines,when sold in the manufacturer’s original pack

3 Aminophylline; for oral use in liquid form in medicines containing 2% or less4 Amorolfine; for external use in medicines containing more than 0.25%5 Aspirin; in slow-release forms; in enteric coated forms containing more than

300 milligrams per dose form6 Azatadine; for oral use in adults and children over 2 years of age7 Azelastine; in medicines for ophthalmic use containing 0.05% or less8 Brompheniramine; for oral use in medicines for adults or children over 2 years

of age other than in medicines used for the treatment of insomnia; for oral usefor the treatment of insomnia when sold in the manufacturer’s original packcontaining not more than 10 dosage units

9 Buclizine; for oral use10 Butoconazole; for vaginal use11 Chloramphenicol; for ophthalmic use; except when sold in practice by an

optometrist registered with the Optometrists and Dispensing Opticians Board12 Chlorbutol; except when specified elsewhere in this schedule13 Chlorpheniramine; for oral use in medicines for adults or children over 2 years


14 Ciclopirox; for external use in medicines containing more than 2%; in prepar-ations for application to the nails containing more than 8%

15 Cimetidine; in medicines for the symptomatic relief of heartburn, dyspepsia,and hyperacidity or to be used on the recommendation of a registered medical


71

practitioner, when sold in the manufacturer’s original pack containing not morethan 14 days’ supply

16 Clemastine; for oral use17 Clobetasone; for dermal use in medicines containing 0.05% or less and in

packs containing not more than 30 grams that have received the consent of theMinister or the Director-General to their distribution as restricted medicines,when sold in the manufacturer’s original pack

18 Clotrimazole; for vaginal use19 Codeine; in medicines for oral use containing not more than 15 milligrams of

codeine per solid dosage unit or per dose of liquid with a maximum daily dosenot exceeding 100 milligrams of codeine, when combined with 1 or moreactive ingredients in such a way that the substance cannot be recovered byreadily applicable means or in a yield that would constitute a risk to health, foruse as an analgesic and when sold in a pack of not more than 5 days’ supply,approved by the Minister or the Director-General for distribution as a restrictedmedicine

20 Cyclizine; for oral use other than in medicines used for the treatment of insom-nia when sold in the manufacturer’s original pack containing not more than 6dosage units; for oral use in medicines used for the treatment of insomnia whensold in the manufacturer’s original pack containing not more than 10 dosageunits

21 Cyproheptadine; for oral use22 Dexchlorpheniramine; for oral use in medicines for adults or children over 2

years of age other than in medicines used for the treatment of insomnia; fororal use for the treatment of insomnia when sold in the manufacturer’s originalpack containing not more than 10 dosage units

23 Di-iodohydroxy quinoline; for vaginal use24 Diclofenac; in solid dose form in medicines containing 25 milligrams or less

and more than 12.5 milligrams per dose form in packs containing not morethan 30 tablets or capsules

25 Dimenhydrinate; for oral use in medicines for adults and children over 2 yearsof age; except when specified elsewhere in this schedule

26 Dimethindene; for oral use27 Diphenhydramine; for oral use in medicines for adults or children over 2 years


28 Dithranol29 Doxylamine; for oral use in medicines for adults or children over 2 years of age

other than in medicines used for the treatment of insomnia; for oral use for the


72

treatment of insomnia when sold in the manufacturer’s original pack containingnot more than 10 dosage units

30 Econazole; for vaginal use31 Erythrityl tetranitrate32 Famciclovir; in divided solid dosage forms for oral use containing 500 milli-

grams or less for the treatment of recurrent herpes labialis when sold in themanufacturer’s original pack containing up to 3 dosage units

33 Flavoxate34 Fluconazole; for oral use in medicines that have received the consent of the

Minister or the Director-General to their distribution as restricted medicines,when sold in the manufacturer’s original pack containing 150 milligrams orless as a single dose for the treatment of vaginal candidiasis

35 Fluorides; for external use in liquid form in medicines containing 5.5 grams orless and more than 1 gram per litre or per kilogram and when sold in packsapproved by the Minister or the Director-General for distribution as restrictedmedicines; for external use in non-liquid form in medicines containing 5.5grams or less and more than 1 gram per litre or per kilogram, except in medi-cines containing 1.5 grams or less and more than 1 gram per litre or per kilo-gram; except when supplied to a dental professional registered with the DentalCouncil

36 Glucagon; except in medicines containing 100 micrograms or less per litre orper kilogram

37 Glyceryl trinitrate; for oral or sublingual use; for rectal use38 Guaifenesin; for oral use in modified release form with a maximum recommen-

ded daily dose of not more than 2.4 grams when sold in the manufacturer’s ori-ginal pack containing more than 10 days’ supply but not more than 30 days’supply; except for oral use in modified release form with a maximum recom-mended daily dose of not more than 2.4 grams when sold in the manufacturer’soriginal pack containing not more than 10 days’ supply; except for oral use inmedicines containing 2% or less or 200 milligrams or less per dose form

39 Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacte-rial complications of colds

40 Hydrocortisone and hydrocortisone acetate but no other esters of hydrocorti-sone; for dermal use in medicines containing 1% or less but more than 0.5% byweight of hydrocortisone base with no other active ingredient except an anti-fungal and in a quantity of 30 grams or less or 30 millilitres or less per con-tainer; for dermal use in medicines containing 1% or less but more than 0.5%by weight of hydrocortisone base with no other active ingredient except 5% orless by weight of aciclovir and in a quantity of 2 grams or less or 2 millilitresor less per container in adults and children 12 years of age and older; in rectalmedicines containing 1% or less but more than 0.5% by weight of hydrocorti-


73

sone base and in combination with a local anaesthetic and in a quantity of 35grams or less per container or up to 12 suppositories per pack

41 Hyoscine butylbromide; for oral use in medicines containing not more than 20milligrams per dose form and in packs containing not more than 10 tablets orcapsules for the relief of muscle spasm of the gastrointestinal tract

42 Ibuprofen; for oral use in tablets or capsules containing up to 400 milligramsper dose form and in packs containing not more than 50 dose units and thathave received the consent of the Minister or the Director-General to their distri-bution as restricted medicines, when sold in the manufacturer’s original packlabelled for use by adults or children over 12 years of age

43 Inositol nicotinate44 Isoconazole; for vaginal use45 Ketoprofen; in solid dose form containing 25 milligrams or less per dose form

in packs of not more than 30 capsules or tablets46 Lansoprazole; in divided solid dosage forms for oral use containing 15 milli-

grams or less with a maximum daily dose of 15 milligrams for the short-termsymptomatic relief of gastric reflux-like symptoms in sufferers aged 18 yearsand over for the relief of heartburn when sold in the manufacturer’s originalpack containing not more than 14 dosage units

47 Levonorgestrel; in medicines for use as emergency post-coital contraceptionwhen in packs containing not more than 1.5 milligrams

48 Macrogols; in oral preparations for bowel cleansing prior to diagnostic, med-ical, or surgical procedures

49 Malathion; except for external use in medicines containing 2% or less50 Mannityl hexanitrate51 Meclozine; in a pack size of up to 10 dosage units for the treatment of insom-

nia52 Mepyramine; for oral use in medicines for adults or children over 2 years of

age other than in medicines used for the treatment of insomnia; for oral use forthe treatment of insomnia when sold in the manufacturer’s original pack con-taining not more than 10 dosage units

53 Methdilazine; for oral use54 Metoclopramide; when compounded with paracetamol in packs of not more

than 10 tablets or capsules for the treatment of nausea associated with migraine55 Miconazole; for the treatment of oral candidiasis; for vaginal use56 Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or

less but more than 100 milligrams per dose form; except in medicines contain-ing 100 milligrams or less per dose form

57 Nicotinyl alcohol; except in medicines containing 100 milligrams or less perdose form


74

58 Nystatin; for the treatment of oral candidiasis; for vaginal use59 Orlistat; in medicines for weight control containing 120 milligrams or less per

dose form60 Oseltamivir; in solid dosage forms for oral use containing 75 milligrams in a

pack size of up to 10 dosage units for the treatment or prophylaxis of influenzain adults and children aged 13 years and older who have been exposed to theinfluenza virus

61 Oxiconazole; for vaginal use62 Pheniramine; for oral use in medicines for adults or children over 2 years of


63 Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial com-plications of colds

64 Podophyllotoxin; for external use for the treatment of warts other than anogeni-tal warts in medicines containing 1% or less and more than 0.5%; except inmedicines containing 1 milligram or less of podophyllin per litre or per kilo-gram

65 Podophyllum emodi; for external use for the treatment of warts other than ano-genital warts in medicines containing 20% or less and more than 10% of podo-phyllin; except in medicines containing 1 milligram or less of podophyllin perlitre or per kilogram

66 Podophyllum peltatum; for external use for the treatment of warts other thananogenital warts in medicines containing 20% or less and more than 10% ofpodophyllin; except in medicines containing 1 milligram or less of podophyllinper litre or per kilogram

67 Prochlorperazine; in packs containing not more than 10 tablets or capsules forthe treatment of nausea associated with migraine

68 Promethazine; for oral use in medicines for adults or children over 2 years ofage other than in medicines used for the treatment of insomnia; for oral use forthe treatment of insomnia when sold in the manufacturer’s original pack con-taining not more than 10 dosage units

69 Rizatriptan; for oral use in medicines for the acute relief of migraine attackswith or without aura in patients who have a stable, well-established pattern ofsymptoms, when in wafers containing 5 milligrams or less per wafer and whensold in a pack containing not more than 2 wafers approved by the Minister orthe Director-General for distribution as a restricted medicine

70 Salicylic acid; except in medicines for dermal use containing 40% or less71 Santonin


75

72 Sodium phosphate; in oral preparations for bowel cleansing prior to diagnostic,medical, or surgical procedures

73 Sodium picosulphate; in oral preparations for bowel cleansing prior to diagnos-tic, medical, or surgical procedures

74 Staphyloccocus aureus vaccine; in oral vaccines for the prophylaxis of bacterialcomplications of colds

75 Stramonium; for oral use in liquid form; in solid dose form in medicines con-taining more than 0.3 milligrams per dose or more than 1.2 milligrams per rec-ommended daily dose

76 Streptococcus beta-haemolyticus vaccine; in oral vaccines for the prophylaxisof bacterial complications of colds

77 Sulfacetamide; for ophthalmic use in medicines containing 10% or less78 Sumatriptan; for oral use in medicines for the acute relief of migraine attacks

with or without aura in patients who have a stable, well-established pattern ofsymptoms when in tablets containing 50 milligrams or less per tablet and whensold in a pack containing not more than 2 tablets that has received the consentof the Minister or the Director-General to its sale as a restricted medicine

79 Theophylline; in liquid form for oral use in medicines containing 2% or less80 Tioconazole; for vaginal use81 Triamcinolone; for buccal use in medicines containing 0.1% or less of triamci-

nolone acetonide and in pack sizes of 5 grams or less82 Trimeprazine; for oral use in medicines for adults or children over 2 years of


83 Triprolidine; for oral use in medicines for adults and children over 2 years ofage; except when specified elsewhere in this schedule

84 Zolmitriptan; in a pre-filled nasal spray device containing not more than 5 mil-ligrams of zolmitriptan, for the acute relief of migraine attacks with or withoutaura in patients who have a stable, well-established pattern of symptoms andwhen sold in a pack of not more than 2 devices approved by the Minister or theDirector-General for distribution as a restricted medicine

Part 3Pharmacy-only medicines

1 8-hydroxyquinoline and its non-halogenated derivatives; in medicines contain-ing more than 1% of such substances; except for hydroxyquinoline sulphate forexternal use

2 Acetic acid and preparations containing more than 80% of acetic acid(CH3COOH); excluding its salts and derivatives


76

3 Acetylcysteine; for oral use in medicines containing more than 1 gram per rec-ommended daily dose

4 Aciclovir; for external use for the treatment of herpes labialis except in medi-cines containing 5% or less and in tubes containing 10 grams or less

5 Aconitum spp; for oral use in packs containing 0.2 milligrams or less and morethan 0.02 milligrams of total alkaloids; for dermal use in concentrations of0.02% or less and in packs containing 0.2 milligrams or less and more than0.02 milligrams of total alkaloids

6 Aloes; for internal use; except when obtained solely from the mucilaginous gelof the leaf

7 Aloin8 Aloxiprin9 Amethocaine; for external use in medicines containing 10% or less and more

than 2%; except in medicines for external use containing 2% or less10 Amorolfine; in preparations for topical use; except in preparations for the treat-

ment of tinea pedis only or when sold in practice by a podiatrist registered withthe Podiatrists Board

11 Antazoline; for ophthalmic use except when sold in practice by an optometristregistered with the Optometrists and Dispensing Opticians Board

12 Atropa belladonna; for external use in medicines containing 0.03% or less ofthe alkaloids of belladonna; for oral use in liquid form in medicines containing0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milli-grams per recommended daily dose of the alkaloids of belladonna or in soliddose form in medicines containing 0.3 milligrams or less per dose form and notmore than 1.2 milligrams per recommended daily dose of the alkaloids of bel-ladonna

13 Atropine; for oral use in liquid form in medicines containing 0.03% or less and0.3 milligrams or less per dose and not more than 1.2 milligrams per recom-mended daily dose or in solid dose form in medicines containing 0.3 milli-grams or less per dose form and not more than 1.2 milligrams per recommen-ded daily dose; in medicines containing atropine sulphate for the treatment oforganophosphorus poisoning either in packs of not more than 20 dose unitscontaining 0.6 milligrams or less per dose unit or in injections in packs of notmore than 5 vials containing 0.6 milligrams per millilitre; except when sold asan antidote in a device designed for self-injection from outlets licensed to sellorganophosphorus poisons; except in medicines containing 300 micrograms orless per litre or per kilogram

14 Azelaic acid; for dermal use15 Azelastine; in preparations for nasal use containing 0.15% azelastine hydro-

chloride or less; in topical eye preparations containing 0.05% or less


77

16 Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adultsand children over 12 years of age in aqueous nasal sprays delivering up to 50micrograms per actuation when the maximum recommended daily dose is nogreater than 400 micrograms (200 micrograms per nostril) in a pack containing200 actuations or less

17 Benzocaine; in preparations for topical use, other than eye drops, containing10% or less of total anaesthetic substances except in dermal preparations con-taining 2% or less of total anaesthetic substances; in divided preparations con-taining 200 milligrams or less of total anaesthetic substances per dosage unitexcept in lozenges containing 30 milligrams or less of total anaesthetic sub-stances per dosage unit

18 Benzoyl peroxide; for external use in medicines containing more than 5% andnot more than 10%; except for medicines for external use containing 5% or less

19 Benzydamine; for external use except for oromucosal or topical use20 Bephenium21 Bifonazole; except when specified elsewhere in this schedule; except for der-

mal use in medicines for tinea pedis only or in shampoos containing 1% or lessor when sold in practice by a podiatrist registered with the Podiatrists Board

22 Bilastine; in divided solid dosage forms for oral use containing 20 milligramsor less for the treatment of the symptoms of allergic rhinoconjunctivitis (sea-sonal and perennial) and urticaria when sold in a pack containing not more than30 dosage units

23 Bisacodyl24 Bromhexine25 Brompheniramine; for oral use in medicines for adults and children over 6

years of age when combined in the same container with 1 or more other thera-peutically active ingredients either when in the bedtime dose of a day/nightpack containing brompheniramine or when at least 1 of the other active ingre-dients is a sympathomimetic decongestant

26 Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults andchildren over 12 years of age in aqueous nasal sprays delivering up to 50micrograms per actuation and when the maximum recommended daily dose isno greater than 400 micrograms (200 micrograms per nostril) in a pack con-taining 200 actuations or less

27 Carbetapentane; except in medicines containing 0.5% or less28 Carbocisteine29 Cetirizine; for oral use except in divided solid dosage forms for oral use con-

taining 10 milligrams or less of cetirizine hydrochloride per dose form for thetreatment of seasonal allergic rhinitis when sold in the manufacturer’s originalpack containing not more than 5 days’ supply


78

30 Chlophedianol31 Chlorbutol; in medicines containing 5% or less and more than 0.5%; except in

medicines containing 0.5% or less32 Chloroform; in medicines other than for anaesthesia containing more than

0.5%; except in medicines containing 0.5% or less33 Chlorpheniramine; for oral use in medicines for adults and children over 6

years of age when combined in the same container with 1 or more other thera-peutically active ingredients either when in the bedtime dose of a day/nightpack containing chlorpheniramine or when at least 1 of the other active ingredi-ents is a sympathomimetic decongestant

34 Ciclopirox; for external use in medicines containing 2% or less except whenfor the treatment of tinea pedis only or when sold in practice by a podiatristregistered with the Podiatrists Board; in preparations for application to the nailscontaining 8% or less

35 Cinchocaine; for external use in medicines containing 0.5% or less36 Cinnamedrine37 Clotrimazole; for external use except in medicines for tinea pedis only or when

sold in practice by a podiatrist registered with the Podiatrists Board38 Cocaine; in medicines for oral use, containing not more than 0.1% of cocaine,

when combined with 1 or more active ingredients in such a way that the sub-stance cannot be recovered by readily applicable means or in a yield that wouldconstitute a risk to health, and when sold in a pack approved by the Minister orthe Director-General for distribution as a pharmacy-only medicine

39 Codeine; in medicines for oral use, containing not more than 15 milligrams ofcodeine per solid dosage unit or per dose of liquid with a maximum daily dosenot exceeding 100 milligrams of codeine, when combined with 1 or moreactive ingredients in such a way that the substance cannot be recovered byreadily applicable means or in a yield that would constitute a risk to health, forthe treatment of the symptoms of cough and cold and when sold in a pack ofnot more than 6 days’ supply, approved by the Minister or the Director-Generalfor distribution as a pharmacy-only medicine

40 Colocynth41 Creosote; except in medicines containing 10% or less42 Cresols; except in medicines containing 3% or less43 Datura spp; for oral use in liquid form in medicines containing 0.03% or less

and 0.3 milligrams or less per dose and not more than 1.2 milligrams per rec-ommended daily dose of total solanaceous alkaloids; in solid dose form inmedicines containing 0.3 milligrams or less per dose form and not more than1.2 milligrams per recommended daily dose of total solanaceous alkaloids

44 Delphinium staphisagria; except in medicines containing 0.2% or less


79

45 Desloratadine; for oral use46 Dexchlorpheniramine; for oral use in medicines for adults and children over 6

years of age when combined in the same container with 1 or more other thera-peutically active ingredients either when in the bedtime dose of a day/nightpack containing dexchlorpheniramine or when at least 1 of the other activeingredients is a sympathomimetic decongestant

47 Dextromethorphan; in liquid form containing more than 0.25% or in solid doseform containing more than 15 milligrams per dose form when in packs contain-ing not more than 600 milligrams and with a recommended daily dose of notmore than 120 milligrams; in medicines for the treatment of the symptoms ofcough and cold in children aged 6–12 years; except in liquid form containing0.25% or less in solid dose form containing 15 milligrams or less per dose formwhen in packs containing not more than 600 milligrams and with a recommen-ded daily dose of not more than 120 milligrams

48 Dibrompropamidine; for ophthalmic use except when sold in practice by anoptometrist registered with the Optometrists and Dispensing Opticians Board

49 Diclofenac; in solid dose form in medicines containing 12.5 milligrams or lessper dose form in packs containing not more than 30 tablets or capsules andwith a recommended daily dose of not more than 75 milligrams

50 Diphenoxylate; in liquid form containing in each millilitre not more than 0.5milligrams of diphenoxylate calculated as base and not less than 5 microgramsof atropine sulphate; in solid dose form containing not more than 2.5 milli-grams of diphenoxylate calculated as base and not less than 5 micrograms ofatropine sulphate

51 Dimenhydrinate; for oral use in a sealed container of not more than 10 tabletsor capsules for the prevention or treatment of motion sickness in adults or chil-dren over 2 years of age except when sold at a transport terminal or aboard aship or an aircraft

52 Diphenhydramine; for oral use in medicines for adults and children over 6years of age when combined in the same container with 1 or more other thera-peutically active ingredients either when in the bedtime dose of a day/nightpack containing diphenhydramine or when at least 1 of the other active ingredi-ents is a sympathomimetic decongestant; for oral use in a sealed container ofnot more than 10 tablets or capsules for the prevention or treatment of motionsickness in adults and children over 2 years of age except when sold at a trans-port terminal or aboard a ship or an aircraft

53 Doxylamine; for oral use in medicines for adults and children over 6 years ofage when combined in the same container with 1 or more other therapeuticallyactive ingredients either when in the bedtime dose of a day/night pack contain-ing doxylamine or when at least 1 of the other active ingredients is a sympatho-mimetic decongestant


80

54 Duboisia leichhardtii; for oral use in liquid form in medicines containing0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milli-grams per recommended daily dose of total solanaceous alkaloids; in solid doseform in medicines containing 0.3 milligrams or less per dose form and notmore than 1.2 milligrams per recommended daily dose of total solanaceousalkaloids

55 Duboisia myoporides; for oral use in liquid form in medicines containing0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milli-grams per recommended daily dose of total solanaceous alkaloids; in solid doseform in medicines containing 0.3 milligrams or less per dose form and notmore than 1.2 milligrams per recommended daily dose of total solanaceousalkaloids

56 Econazole; for dermal use except in medicines for tinea pedis only or whensold in practice by a podiatrist registered with the Podiatrists Board

57 Esomeprazole; in oral preparations containing 20 milligrams or less per dosageunit for the relief of heartburn and other symptoms of gastro-oesophagealreflux disease, in packs containing not more than 14 days’ supply

58 Etafedrine59 Ether; in medicines containing more than 10%; except in medicines containing

10% or less60 Etofenamate; for external use61 Famotidine; for the symptomatic relief of heartburn, dyspepsia, and hyperacid-

ity or to be used on the recommendation of a registered medical practitioner,when sold in the manufacturer’s original pack containing not more than 14days’ supply

62 Felbinac; for external use63 Fexofenadine; for oral use except for the treatment of seasonal allergic rhinitis

in adults and children 12 years of age and over when in capsules containing 60milligrams or less of fexofenadine hydrochloride or in tablets containing 120milligrams or less of fexofenadine hydrochloride with a maximum daily doseof 120 milligrams when sold in the manufacturer’s original pack containing 10dosage units or less and not more than 5 days’ supply

64 Fluorides; for internal use in medicines containing 0.5 milligrams or less perdose unit; except in parenteral nutrition replacement preparations; for externaluse in liquid form in medicines containing 1 gram or less per litre or per kilo-gram and when sold in packs approved by the Minister or the Director-Generalfor distribution as pharmacy-only medicines except in medicines containing220 milligrams or less per litre or per kilogram and in packs containing notmore than 120 milligrams of total fluoride; except when supplied to any dentalprofessional registered with the Dental Council; except in medicines containing15 milligrams or less per litre or per kilogram


81

65 Flurbiprofen; in locally acting oromucosal preparations containing 10 milli-grams or less per dosage unit

66 Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults andchildren over 12 years of age when in aqueous nasal sprays delivering up to 50micrograms per actuation with a maximum recommended daily dose of 200micrograms (as a single dose) in a pack containing 200 actuations or less

67 Folic acid; for oral use in medicines containing more than 500 micrograms perrecommended daily dose; except for oral use in medicines containing 500micrograms or less per recommended daily dose; except in parenteral nutritionreplacement preparations

68 Folinic acid; for oral use in medicines containing more than 500 microgramsper recommended daily dose; except for oral use in medicines containing 500micrograms or less per recommended daily dose

69 Formaldehyde; except in medicines containing 5% or less70 Gelsemium sempervirens; except in medicines containing 1 milligram or less

per litre or per kilogram71 Glutaraldehyde72 Hexachlorophane; in medicines containing 3% or less but more than 0.75%;

except in medicines containing 0.75% or less73 Hydrocortisone and hydrocortisone acetate but no other esters of hydrocorti-

sone; for dermal use in medicines containing 0.5% or less by weight of hydro-cortisone base with no other active ingredient except an antifungal and in aquantity of 30 grams or less or 30 millilitres or less per container; in rectalmedicines containing 0.5% or less by weight of hydrocortisone base and incombination with a local anaesthetic and in a quantity of 35 grams or less percontainer or 12 suppositories or fewer per pack

74 Hydrocyanic acid; for oral use in packs containing 5 milligrams or less andmore than 0.5 milligrams; except in medicines containing 1 microgram or lessper litre or per kilogram; except for oral use in packs containing 0.5 milligramsor less

75 Hydroquinone; for external use in medicines containing 2% or less except inhair preparations containing 1% or less

76 Hyoscine; for transdermal use in medicines containing 2 milligrams or less oftotal solanaceous alkaloids per dose unit; for oral use in liquid form in medi-cines containing 0.03% or less and 0.3 milligrams or less per dose and notmore than 1.2 milligrams per recommended daily dose of total solanaceousalkaloids; in solid dose form in medicines containing 0.3 milligrams or less perdose form and not more than 1.2 milligrams per recommended daily dose oftotal solanaceous alkaloids

77 Hyoscyamine; for external use in medicines containing 0.03% or less of totalsolanaceous alkaloids; for oral use in liquid form in medicines containing


82

0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milli-grams per recommended daily dose of total solanaceous alkaloids; in solid doseform in medicines containing 0.3 milligrams or less per dose form and notmore than 1.2 milligrams per recommended daily dose of total solanaceousalkaloids

78 Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03%or less (300 micrograms or less of total solanaceous alkaloids per litre or perkilogram) and 0.3 milligrams or less per dose and not more than 1.2 milligramsper recommended daily dose of total solanaceous alkaloids or in solid doseform in medicines containing 0.3 milligrams or less per dose form and notmore than 1.2 milligrams per recommended daily dose except in packs contain-ing 30 micrograms or less of total solanaceous alkaloids

79 Ibuprofen; for oral use in liquid form with a recommended daily dose of notmore than 1.2 grams for the relief of pain and reduction of fever or inflamma-tion when sold in the manufacturer’s original pack containing not more than 8grams; for oral use in solid dose form containing not more than 200 milligramsper dose form and with a recommended daily dose of not more than 1.2 gramswhen sold in the manufacturer’s original pack containing not more than 100dose units; except in divided solid dosage forms for oral use containing 200milligrams or less per dose form with a recommended daily dose of not morethan 1.2 grams and when sold in the manufacturer’s original pack containingnot more than 25 dose units; except for external use

80 Indanazoline81 Indomethacin; for external use in medicines containing 1% or less; except in

medicines containing 1 milligram or less per litre or per kilogram82 Iodine; except for external use in medicines containing 2.5% or less; for inter-

nal use in medicines containing less than 300 micrograms per recommendeddaily dose

83 Ipecacuanha; in medicines containing 0.2% or less of emetine and 40 micro-grams or more of ipecacuanha alkaloids per recommended dose for the treat-ment of the symptoms of cough and cold in children aged 6–12 years; except inmedicines containing less than 40 micrograms of ipecacuanha alkaloids perrecommended dose for the treatment of the symptoms of cough and cold inchildren aged 6–12 years

84 Ipomoea spp; except ipomoea batatas85 Ipratropium; for nasal use86 Iron; for oral use either in medicines containing more than 24 milligrams per

recommended daily dose or in medicines containing more than 5 milligramsper dose unit and more than 750 milligrams of iron per pack; except in paren-teral nutrition replacement preparations; except for oral use in medicines con-taining 24 milligrams or less per recommended daily dose in medicines con-taining not more than 5 milligrams per dose unit; except for oral use in medi-


83

cines containing 24 milligrams or less per recommended daily dose in medi-cines containing more than 5 milligrams per dose unit in packs containing notmore than 750 milligrams of iron

87 Isoconazole; for dermal use except when sold in practice by a podiatrist regis-tered with the Podiatrists Board

88 Isopropamide; for dermal use in preparations containing 2% or less89 Jalap resin90 Ketoconazole; for dermal use except in medicines for tinea pedis only or when

sold in practice by a podiatrist registered with the Podiatrists Board; except inmedicines for treatment of the scalp containing 1% or less

91 Ketotifen; for ophthalmic use in medicines containing 0.025% or less exceptwhen sold in practice by an optometrist registered with the Optometrists andDispensing Opticians Board

92 Leucovorin; in medicines containing more than 500 micrograms per recom-mended daily dose

93 Levocabastine; for nasal use; for ophthalmic use except when sold in practiceby an optometrist registered with the Optometrists and Dispensing OpticiansBoard

94 Levocetirizine; for oral use95 Lignocaine; for urethral use; for external use in medicines containing 10% or

less and more than 2%96 Lindane; for external use in medicines containing 2% or less97 Lithium; for dermal use in medicines containing 1% or less but more than

0.01%; except for dermal use in medicines containing 0.01% or less98 Lobelia inflata; except in medicines for smoking or burning99 Lobeline; except when in medicines for smoking or burning100 Lodoxamide; for ophthalmic use except when sold in practice by an optomet-

rist registered with the Optometrists and Dispensing Opticians Board101 Loperamide; in packs containing not more than 20 tablets or capsules; except

in divided solid dosage forms for oral use containing 2 milligrams or less ofloperamide per dosage form when sold in a pack containing not more than 8dosage forms approved by the Minister or the Director-General for distributionas a general sales medicine for the symptomatic treatment of acute non-specificdiarrhoea

102 Loratadine; for oral use; except in divided solid dosage forms for oral use con-taining 10 milligrams or less per dose form for the treatment of seasonal aller-gic rhinitis when sold in the manufacturer’s original pack containing not morethan 10 days’ supply

103 Macrogols; in preparations for oral use as a liquid concentrate for laxative use


84

104 Mebendazole105 Meclozine; in a sealed container of not more than 12 tablets or capsules for the

prevention or treatment of travel sickness except when sold at a transport ter-minal or aboard a ship or aircraft

106 Mefenamic acid; in solid dose form in packs containing not more than 30 tab-lets or capsules for the treatment of dysmenorrhoea

107 Mepyramine; for dermal use; except for external use in medicines containing2% or less in packs not exceeding 25 grams

108 Mercuric oxide; for ophthalmic use109 Mercurochrome; in preparations for external use containing 2% or less110 Mercury; for external use in medicines containing 0.5% or less; except in med-

icines containing 1 milligram or less per litre or per kilogram111 Methoxamine; for external use in medicines containing more than 1%; except

for external use in medicines containing 1% or less112 Methoxyphenamine113 Methylephedrine114 Miconazole; for external use except in medicines for tinea pedis only or when

sold in practice by a podiatrist registered with the Podiatrists Board115 Minoxidil; for dermal use in medicines containing 5% or less116 Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and

children over 12 years of age in aqueous nasal sprays delivering up to 50micrograms per actuation when the maximum recommended daily dose is nogreater than 200 micrograms (as a single dose) in a pack containing 200 actua-tions or less

117 Morphine; in medicines for oral use containing not more than 0.2% of mor-phine, when combined with 1 or more active ingredients in such a way that thesubstance cannot be recovered by readily applicable means or in a yield thatwould constitute a risk to health, when sold in a pack approved by the Ministeror the Director-General for distribution as a pharmacy-only medicine

118 Naphazoline; except for ophthalmic use when sold in practice by an optomet-rist registered with the Optometrists and Dispensing Opticians Board

119 Naproxen; in solid dose form containing 250 milligrams or less per dose formin packs of not more than 30 tablets or capsules

120 Niclosamide121 Nicotine; for inhalation except when sold from a smoking cessation clinic run

under the auspices of a registered medical practitioner, nurse, pharmacist, orpsychologist

122 Nizatidine; in medicines for the symptomatic relief of heartburn, dyspepsia,and hyperacidity or to be used on the recommendation of a registered medical


85

practitioner, when sold in the manufacturer’s original pack containing not morethan 14 days’ supply

123 Noscapine124 Nystatin; for dermal use except when sold in practice by a podiatrist registered

with the Podiatrists Board; except in medicines for tinea pedis only or whensold in practice by a podiatrist registered with the Podiatrists Board

125 Omeprazole; in divided solid dosage forms for oral use containing 20 milli-grams or less with a maximum daily dose of 20 milligrams for the short-termsymptomatic relief of gastric reflux-like symptoms in sufferers aged 18 yearsand over when sold in the manufacturer’s original pack containing not morethan 28 dosage units

126 Opium; in medicines for oral use containing not more than 0.2% of morphine,when combined with 1 or more active ingredients in such a way that the sub-stance cannot be recovered by readily applicable means, or in a yield thatwould constitute a risk to health, when sold in a pack approved by the Ministeror the Director-General for distribution as a pharmacy-only medicine

127 Oxetacaine; for internal use128 Oxiconazole; for dermal use except in medicines for tinea pedis only129 Oxymetazoline; except for nasal use when sold at an airport; except for oph-

thalmic use when sold in practice by an optometrist registered with the Optom-etrists and Dispensing Opticians Board; except for nasal use in medicines con-taining 0.05% or less when sold in the manufacturer’s original pack with apack size of 20 millilitres or less

130 Pantoprazole; in divided solid dosage forms for oral use containing 20 milli-grams or less with a maximum daily dose of 20 milligrams for the short-termsymptomatic relief of gastric reflux-like symptoms in sufferers aged 18 yearsand over when sold in the manufacturer’s original pack containing not morethan 28 dosage units

131 Papaverine; except for injection132 Paracetamol; in liquid form; in suppositories; in tablets or capsules containing

500 milligrams or less and in packs containing more than 10 grams and notmore than 50 grams; in slow-release forms containing 665 milligrams or lessand more than 500 milligrams; in powder form containing not more than 1gram per sachet and more than 10 grams per pack; except in tablets or capsulescontaining 500 milligrams or less and in packs containing not more than 10grams; except in powder form in sachets containing 1 gram or less and in packsof not more than 10 grams

133 Paraformaldehyde; except in medicines containing 5% or less134 Penciclovir; for external use for the treatment of herpes labialis; except in med-

icines for external use containing 1% or less in a pack containing 10 grams orless for the treatment of herpes labialis


86

135 Phedrazine136 Phenazone; for external use137 Pheniramine; for ophthalmic use except when sold in practice by an optomet-

rist registered with the Optometrists and Dispensing Opticians Board; for oraluse in medicines for adults and children over 6 years of age when combined inthe same container with 1 or more other therapeutically active ingredientseither when in the bedtime dose of a day/night pack containing pheniramine orwhen at least 1 of the other active ingredients is a sympathomimetic decongest-ant

138 Phenol; except in medicines other than for injection containing 3% or less139 Phenylephrine; for nasal use in medicines containing more than 1%; for oph-

thalmic use in medicines containing 5% or less and more than 1%; for oral usein medicines containing more than 50 milligrams per recommended daily doseor in packs containing more than 250 milligrams of phenylephrine per pack; inmedicines for the treatment of the symptoms of cough and cold in childrenaged 6–12 years; except for nasal or ophthalmic use in medicines containing1% or less; except for oral use in medicines containing 50 milligrams or lessper recommended daily dose and in packs containing 250 milligrams or less ofphenylephrine per pack

140 Pholcodine; in medicines for oral use containing not more than 15 milligramsof pholcodine per solid dosage unit or per dose of liquid with a maximum dailydose not exceeding 100 milligrams of pholcodine, when combined with 1 ormore active ingredients in such a way that the substance cannot be recoveredby readily applicable means, or in a yield that would constitute a risk to health,when sold in a pack approved by the Minister or the Director-General for dis-tribution as a pharmacy-only medicine

141 Piperazine142 Podophyllotoxin; for external use for the treatment of warts other than anogeni-

tal warts in medicines containing 0.5% or less; except in medicines containing1 milligram or less of podophyllin per litre or per kilogram

143 Podophyllum emodi; for external use for the treatment of warts other than ano-genital warts in medicines containing 10% or less of podophyllin; except inmedicines containing 1 milligram or less of podophyllin per litre or per kilo-gram

144 Podophyllum peltatum; for external use for the treatment of warts other thananogenital warts in medicines containing 10% or less of podophyllin; except inmedicines containing 1 milligram or less of podophyllin per litre or per kilo-gram

145 Potassium; for internal use: in slow-release or enteric coated forms; except forinternal use: in medicines containing 100 milligrams or less per recommendeddose; in medicines containing more than 100 milligrams per recommendeddose except in medicines for oral rehydration therapy, parenteral nutrition


87

replacement, or dialysis; except in glucosamine sulphate complexed productscontaining 600 milligrams or less of potassium chloride per recommendeddose; except for external use

146 Potassium chlorate; except in medicines containing 10% or less147 Prilocaine; for dermal use in medicines containing 10% or less of local anaes-

thetic substances148 Procyclidine; for dermal use in medicines containing 5% or less149 Promethazine; for oral use in medicines for adults and children over 6 years of

age when combined in the same container with 1 or more other therapeuticallyactive ingredients either when in the bedtime dose of a day/night pack contain-ing promethazine or when at least 1 of the other active ingredients is a sympa-thomimetic decongestant; for oral use in a sealed container of not more than 10tablets or capsules for the prevention or treatment of motion sickness in adultsand children over 2 years of age except when sold at a transport terminal oraboard a ship or aircraft

150 Propamidine; for ophthalmic use except when sold in practice by an optomet-rist registered with the Optometrists and Dispensing Opticians Board

151 Pyrantel152 Pyrethrins; except in medicines containing 10% or less153 Pyrithione zinc; except in medicines for treatment of the scalp containing 2%

or less154 Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia,

and hyperacidity or to be used on the recommendation of a registered medicalpractitioner when sold in the manufacturer’s original pack containing not morethan 14 days’ supply; except in medicines containing 300 milligrams or lessper dose unit when sold in the manufacturer’s original pack containing notmore than 7 days’ supply

155 Salicylamide156 Selenium; for oral use in medicines containing 300 micrograms or less and

more than 150 micrograms per recommended daily dose; for external useexcept in medicines containing 3.5% or less of selenium sulphide

157 Sennosides158 Silver; except in oral solutions containing 0.3% or less or other medicines con-

taining 1% or less159 Silver sulfadiazine; for external use in pack sizes of 50 grams or less160 Sodium cromoglycate; for nasal use; for ophthalmic use except when sold in

practice by an optometrist registered with the Optometrists and DispensingOpticians Board

161 Sodium nitrite; except for use as an excipient162 Sodium picosulphate; in oral laxative preparations


88

163 Squill; except in medicines containing 1% or less164 Stramonium; for oral use in liquid form in medicines containing 0.03% or less

and 0.3 milligrams or less per dose and not more than 1.2 milligrams per rec-ommended daily dose of total solanaceous alkaloids; in solid dose form inmedicines containing 0.3 milligrams or less per dose form and not more than1.2 milligrams per recommended daily dose of total solanaceous alkaloids

165 Sulconazole; for dermal use166 Sulfadiazine, silver; for external use in pack sizes of 50 grams or less167 Terbinafine; for dermal use except in medicines for tinea pedis only or when

sold in practice by a podiatrist registered with the Podiatrists Board168 Tetrachloroethylene169 Tetrahydrozoline; except for ophthalmic use when sold in practice by an

optometrist registered with the Optometrists and Dispensing Opticians Board170 Thiabendazole171 Tioconazole; for dermal use except in medicines for tinea pedis only or when

sold in practice by a podiatrist registered with the Podiatrists Board172 Tramazoline173 Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and

children over 12 years of age and when in aqueous nasal sprays delivering upto 55 micrograms per actuation when the maximum recommended daily dose isno greater than 220 micrograms and the medicine has received the consent ofthe Minister or the Director-General to its distribution as a pharmacy-onlymedicine

174 Trimeprazine; for oral use in medicines for adults and children over 6 years ofage when combined in the same container with 1 or more other therapeuticallyactive ingredients either when in the bedtime dose of a day/night pack contain-ing trimeprazine or when at least 1 of the other therapeutically active ingredi-ents is a sympathomimetic decongestant

175 Triprolidine; for oral use in medicines for adults and children over 6 years ofage when combined in the same container with 1 or more other therapeuticallyactive ingredients either when in the bedtime dose of a day/night pack contain-ing triprolidine or when at least 1 of the other active ingredients is a sympatho-mimetic decongestant

176 Tuaminoheptane177 Tymazoline178 Xylenols; except in medicines containing 3% or less179 Xylometazoline; except for nasal use when sold at an airport; except for oph-

thalmic use when sold in practice by an optometrist registered with the Optom-etrists and Dispensing Opticians Board

180 Zinc chloride; for dermal use in medicines containing more than 5%


89

Michael Webster,Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.These regulations, which come into force on the 28th day after the date of their notifi-cation in the Gazette, replace Schedule 1 of the Medicines Regulations 1984 (theprincipal regulations). New Schedule 1 sets out an updated list of specified medi-cines and classes of medicines that are declared to be prescription medicines, restric-ted medicines, or pharmacy-only medicines under the Medicines Act 1981 (the Act).The updated list includes medicines that the Minister of Health has previously classi-fied as prescription medicines, etc, by Gazette notice made under section 106 of theAct (see Classification of Medicines (Gazette 2018-go419), Classification of Medi-cines (Gazette 2018-go1290), Classification of Medicines (Gazette 2018-go4068),and Classification of Medicines (Gazette 2018-go4069)). Gazette notices made undersection 106 override any inconsistent classification of medicines in the principal regu-lations, but they do not amend the principal regulations and they cease to have effectafter a period of 6 months (if not revoked sooner).

Issued under the authority of the Legislation Act 2012.Date of notification in Gazette: 27 September 2018.These regulations are administered by the Ministry of Health.

Wellington, New Zealand:

Published under the authority of the New Zealand Government—2018

Explanatory note Medicines Amendment Regulations 2018 2018/179

90




https://gazette.govt.nz/notice/id/2018-go419?year=2018&noticeNumber=go419





Documents

Medicines Amendment Regulations 2018 Regulations · 190 Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection;